MOLECULAR DNA-BASED TESTING FOR BLOOD GROUP ANTIGENS: RECIPIENT-DONOR FOCUS
PRENATAL SCREENING
USE OF GENOMICS FOR DECISION-MAKING IN TRANSFUSION MEDICINE: LABORATORY PRACTICE
1A-H02-01
1A-H02-02
IMPORTANCE OF DOCUMENTATION IN GMP
CHARACTERISTICS AND SEROLOGIC DETERMINATION OF ANTIBODIES TO HIGH FREQUENCY ANTIGENS
DEFINING THE CLINICAL NEED FOR RARE BLOOD CELLS
GLOBAL DEFINITIONS OF RARE DONORS
SELF INSPECTION OF BLOOD ESTABLISHMENTS
GMP REQUIREMENTS FOR PREMISES AND EQUIPMENT IN BLOOD ESTABLISHMENTS
MANAGEMENT OF COMPLAINTS AND PRODUCT RECALL
BLOOD SUPPLY MANAGEMENT (RBC): DEFINITIONS, DESCRIPTION AS A PROCESS, TOOLS FOR ASSESSMENT AND IMPROVEMENT
EXPERIENCE AND RECOMMENDATIONS FROM ASIA PACIFIC
EXPERIENCE AND RECOMMENDATIONS FROM AFRICA
EXPERIENCES AND RECOMMENDATIONS FROM THE NETHERLANDS
1C-H06-01
DONOR SELECTION FOR RECIPIENT SAFETY
TESTING FOR ESTABLISHED VIRUSES: FROM THE SCREENING TO THE CONFIRMATION
AN UPDATE ON TRACEABILITY CHALLENGES - WHAT, HOW MUCH & HOW LONG?
TRACKING BLOOD PRODUCTS IN HOSPITALS USING RADIO FREQUENCY IDENTIFICATION: LESSONS FROM A PILOT IMPLEMENTATION
APPLICATION VALIDATION VS INFRASTRUCTURE QUALIFICATION
TRANSFUSION RISK REDUCTION: TESTING FOR BACTERIA
CURRENT PERSPECTIVES IN TRANSFUSION-TRANSMITTED INFECTIOUS DISEASES: EMERGING AND IMPORTED INFECTIONS, INCLUDING PARASITES
UPDATE ON PATHOGEN REDUCTION TECHNOLOGY
TRANSFORMATION OF EVIDENCE TO KNOWLEDGE: A NEGLECTED TASK WITHIN THE MEDICAL PROFESSION
THE EVIDENCE BASE FOR RED BLOOD CELL TRANSFUSIONS
BENCHMARKING: APPLICATIONS TO TRANSFUSION MEDICINE
THE DETRIMENTAL ASPECTS OF CRYOPRESERVATION OF MSC
THE EFFECT OF TIMING OF GAMMA-IRRADIATION ON HEMOLYSIS AND POTASSIUM RELEASE IN RED CELL CONCENTRATES
IN VITRO EVALUATION OF PEDIATRIC ERYTHROCYTE CONCENTRATES STORED IN PAGGS-M IN FOUR DIFFERENT STORAGE CONTAINERS
APHERESIS PLATELET CONCENTRATES CONTAINING VISIBLE PARTICLES ARE NOT INFERIOR TO PARTICLE-FREE CONCENTRATES, IN VITRO
QUALITY OF BLOOD COMPONENTS USING THE REVEOS AUTOMATED BLOOD PROCESSING SYSTEM
ROZROLIMUPAB, A MIXTURE OF RECOMBINANT HUMAN MONOCLONAL ANTI-D ANTIBODIES, FOR THE TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA - A REVIEW
CHARACTERISATION OF ANTIGENICITY OF AN RHD PEPTIDE MIMOTOPE AND ASSESSMENT OF ITS IMMUNOGENICITY IN HLA-DR15 TRANSGENIC MICE
COMBINATION PEPTIDE IMMUNOTHERAPY SUPPRESSES ANTIBODY AND HELPER T CELL RESPONSES TO THE RHD PROTEIN IN HLA-TRANSGENIC MICE
FETAL RHD TYPING CAN BE SAFELY USED TO TARGET BOTH ANTENATAL AND POSTNATAL ANTI-D PROPHYLAXIS
A PROMINENT LACK OF IGG1 FC-FUCOSYLATION OF PLATELET-ALLOANTIBODIES IN PREGNANCY
CORD BLOOD BANKING IN EUROPE AND WORLD WIDE: FACTORS OF ORGANIZATION AND SUSTAINABILITY
2A-S04-02
A DIFFERENT BALANCE IN WNT-SIGNALING IN ADULT AND FETAL BONE MARROW-DERIVED MSC
THE ROLE OF TRUNCATED B3 INTEGRIN IN THE ACTIVATION OF NATURAL KILLER CELL ACTIVITY
DEVELOPMENT OF GMP BASED SINGLE-KIR+ NK CELLS AS ADOPTIVE IMMUNOTHERAPEUTIC OPTION TO ENHANCE THE GRAFT VS LEUKEMIA EFFECT AFTER ALLOGENEIC ATEM CELL TRANSPLANTATION
DEALING WITH DONOR ISSUES IN THERAPEUTIC CELL DONATION
CHARACTERIZATION OF BLOOD DONORS WITH HIGH HAEMOGLOBIN CONCENTRATION
INITIAL REPORT ON FERRITIN TESTING OF BLOOD DONORS
MOTIVATORS AND DETERRENTS TO BLOOD DONATION AMONG BLACK SOUTH AFRICANS: A QUALITATIVE ANALYSIS OF FOCUS GROUP DATA
AN EVALUATION OF THE BLOOD DONOR HEALTH QUESTIONNAIRE (DHQ) IN SWEDEN 2012
BLOOD UTILIZATION
CLINICAL TRIALS ON PLATELETS: RECENT STUDIES AND WHAT NEXT?
CHALLENGES IN THE MANAGEMENT OF THE BLOOD SUPPLY
THE USE OF SOCIAL MEDIA BY EFS
ANTHONY NOLAN'S EXPERIENCE OF RECRUITING 16 AND 17 YEAR OLDS TO THE REGISTRY
2C-S06-03
DEHP PLASTICIZER AND BLOOD BAGS: CHALLENGES AHEAD
3C-S07-02
PLATELET GELS
RHESUSBASE V2: A VERSATILE SOURCE OF INFORMATION ON PUBLISHED RHD ALLELES
MOLECULAR RHD VARIATION OF SEROLOGICAL RHDNEGATIVE WOMEN: IMPLICATIONS FOR A FETAL RHD SCREENING PROGRAMME TO TARGET ANTI-D PROPHYLAXIS
MANAGING DIVERSE MATERNAL RHD VARIANTS IN ALLOIMMUNISED AND NON-ALLOIMMUNISED D NEGATIVE PREGNANT WOMEN DURING FETAL RHD GENOTYPING
MOLECULAR STRUCTURES IDENTIFIED IN SEROLOGICALLY D NEGATIVE SAMPLES OF AN ADMIXED POPULATION
HLA-DRB1*15 IS A MARKER FOR MULTIPLE ANTIBODY RESPONDERS
GENETIC POLYMORPHISMS AND IMMUNE RESPONSE PATHWAYS ASSOCIATED WITH DIFFERENT RESPONDER PROFILES OF RHD-IMMUNISED BLOOD DONORS
EMBRYONIC HEMATOPOIESIS: PROGRAMMING THE ENDOTHELIAL-TO-HEMATOPOIETIC STEM CELL TRANSITION
STEM CELL ORIGINATED RED BLOOD CELL CULTURES: STATUS QUO AND OUTLOOK
2C-S09-03
RECENT INSIGHTS INTO THE MECHANISM OF TRALI
HUMAN ERROR ASSOCIATED WITH MANUAL TECHNIQUES WITH OR WITHOUT AUTOMATION IN ABO/RHD GROUPING ARE ASSOCIATED WITH POTENTIALLY LETHAL OUTCOMES
MANAGEMENT OF IMMUNOGLOBULIN A DEFICIENCY: LESSONS FROM HAEMOVIGILANCE
PRESENCE OF MEDICATION TAKEN BY BLOOD DONORS IN PLASMA FOR TRANSFUSION
STRATEGIES TO IMPROVE REPORTING COMPLIANCE OF DONOR ADVERSE EVENTS
IMAGING OF THE MICROCIRCULATION IN ICU PATIENTS
TRANSFUSION SUPPORT FOR TRAUMA
AN EVALUATION OF THE INFLUENCE OF MAJOR TRANSFUSION PROTOCOL DESIGN ON THE ABILITY OF TRAUMA TEAMS TO PREDICT MASSIVE TRANSFUSION
AN AUSTRALIAN EXPERIENCE IN OUT-OF-HOSPITAL TRANSFUSION OF RED CELL CONCENTRATES BY AIR AMBULANCE PERSONNEL
THE IMPACT OF HIV INFECTION ON OBSTETRIC HEMORRHAGE AND BLOOD TRANSFUSION IN SOUTH AFRICA
CD47 FUNCTIONS AS A MOLECULAR SWITCH FOR ERYTHROCYTE PHAGOCYTOSIS
IN VITRO QUALITY OF RED BLOOD CELLS FOLLOWING SECOND GENERATION S-303 PATHOGEN INACTIVATION TREATMENT
A DIRECT COMPARISON OF THREE PLASTICIZERS FOR PEDIATRIC RED BLOOD CELL STORAGE CONTAINERS: MINIMIZING EXPOSURE TO DEHP
EFFECT OF RED BLOOD CELL (RBC) STORAGE ON BAND 3, 4.1R AND CYTOSKELETAL PROTEINS
LYN DEPENDENT PHOSPHORYLATION OF BAND 3 REGULATES ITS HCO3-/CL- EXCHANGER FUNCTION AND ITS PHYSICAL LINK TO THE SPECTRIN CYTOSKELETON INFLUENCING THE MORPHOLOGICAL ADAPTIVITY OF ERYTHROCYTES
INTEGRATIVE GENOMICS IDENTIFIES SMIM1 AS THE LOCUS OF A NOVEL ERYTHROCYTE MEMBRANE PROTEIN AND THE VEL BLOOD GROUP SYSTEM
THE IMMUNE RESPONSE TO THE VEL ANTIGEN IS HLACLASS II DRB1*11 RESTRICTED
CD59 DEFINES A NEW BLOOD GROUP SYSTEM
SEROLOGICAL AND MOLECULAR CHARACTERISATION OF DOLC, A NOVEL HIGH INCIDENCE ANTIGEN IN THE DOMBROCK BLOOD GROUP SYSTEM
DUPLICATION OF THE UREA TRANSPORTER B GENE (KIDD BLOOD GROUP) IN A KINDRED WITH FAMILIAL AZOTEMIA
HARNESSING CD1D-RESTRICTEDT CELLS TO DESIGN NOVEL VACCINATION STRATEGIES
2D-S14-02
STEM CELL-DERIVED ERYTHROCYTES AS UPCOMING PLAYERS IN BLOOD TRANSFUSION
SERIOUS ADVERSE EVENTS IN UNRELATED STEM CELL DONATIONS
HEALTH OUTCOMES IN RECIPIENTS OF BLOOD TRANSFUSION - OBSERVATIONAL STUDIES VS RANDOMIZED CLINICAL TRIALS
USE OF US DONOR HEMOVIGILANCE SYSTEM TO EVALUATE 3 YEARS OF DATA TO MEASURE EFFECTIVENESS OF STRATEGIES TO REDUCE LOC REACTIONS AMONG YOUNG DONORS
EFFECT OF LONG-TERM WHOLE BLOOD DONATION ON NAIVE T CELL RESERVOIR AND T CELL SUBSETS HOMEOSTASIS
BACTERIAL CONTAMINATION OF BLOOD PRODUCTS
CAN STRICT ANAEROBIC BACTERIA FORM BIOFILMS IN THE AEROBIC PLATELET STORAGE ENVIRONMENT?
MEASURING PLATELET AGGREGATION MAY DETECT BACTERIAL CONTAMINATION IN PLATELET CONCENTRATES
TIME TO DETECTION OF BACTERIAL CONTAMINATION WITH THE IMMUNETICS BACTX TEST IN LEUKOCYTE REDUCED APHERESIS PLATELET UNITS INOCULATED WITH REPRESENTATIVE BACTERIAL SPECIES
SCREENING OF BLOOD DONORS FOR CHRONIC COXIELLA INFECTION IN THE NETHERLANDS
REGULATION OF IMMUNE RESPONSES BY RBC TRANSFUSION
THE MECHANISMS OF ACTION OF IVIG IN AUTOIMMUNE AND INFLAMMATORY DISEASES: AN UPDATE
ETIOLOGY AND PREDICTION RESEARCH, A CONFUSING DISTINCTION: RESULTS FROM ISBT 2012 CANCUN ATTENDEES' SURVEY
THE ASSOCIATION OF IL4 AND RANTES GENE POLYMORPHISM WITH OCCURRENCE OF ALLERGIC TRANSFUSION REACTIONS (ATRS)
3A-S18
MULTIPLE FACTORS DETERMINING THE BIOLOGICAL EFFECT OF ANTI-PLATELET ANTIBODIES
COMPLEMENT: NEW THERAPIES AND EMERGENCE OF THE COMPLOTYPE
SP1/SP3 DOUBLE KNOCKOUT MOUSE MODEL: A TRANSCRIPTION-DEPENDENT BERNARD-SOULIER SYNDROME PHENOCOPY
BACTERIAL BINDING TO COMPLEMENT RECEPTOR 1 ON RED BLOOD CELLS AND TRANSFER TO HUMAN MONOCYTES
3B-PL4
3B-PL5
EVALUATION OF NEURODEGENERATIVE DISEASES AS A THREAT TO THE BLOOD SUPPLY
METAGENOMICS IN VIRUS DISCOVERY
PRELIMINARY INVESTATIONS OF A TRYPANOSOMA CRUZI LINEAGE-SPECIFIC SEROLOGIC ASSAY CAPABLE OF IDENTIFYING INFECTED BLOOD DONORS AT GREATEST RISK FOR TRANSMITTING INFECTION
DENGUE RNA AMONG BLOOD DONORS AND RECIPIENTS DURING LARGE EPIDEMICS OF DENV-4 IN RIO DE JANEIRO AND RECIFE, BRAZIL
BLOOD DONOR SCREENING FOR BABESIA MICROTI: IMPLICATIONS FOR BLOOD SAFETY
PREVALENCE AND TRENDS OF MARKERS OF HEPATITIS B VIRUS, HEPATITIS C VIRUS AND HUMAN IMMUNODEFICIENCY VIRUS IN BLOOD DONORS IN BUENOS AIRES
CLINICAL TRIALS ON PLATELET TRANSFUSION: SUCCESSES AND FAILURES
USE OF TRANEXAMIC ACID BEYOND TRAUMA: TRANEXAMIC ACID FOR THE TREATMENT OF GASTROINTESTINAL HAEMORRHAGE - AN INTERNATIONAL RANDOMISED, DOUBLE BLIND PLACEBO CONTROLLED TRIAL
ACTIVATION AND FUNCTION OF PLATELETS POST FIRE BURN
COMPARISON OF PLATELETS STORED FOR 2-5 VS 6-7 DAYS IN PREVENTING AND TREATING HAEMORRHAGE IN THROMBOCYTOPENIC PATIENTS - A RANDOMISED CONTROLLED TRIAL
ASSESSMENT OF ROTATIONAL THROMBOELASTOMETRY IN CARDIAC SURGERY: CORRECT PREDICTION OF CLINICALLY RELEVANT THROMBOCYTOPENIA AND HYPOFIBRINOGENAEMIA AFTER 5 MIN
EVOLUTION OF THE ABO SUPERGENE FAMILY
MOLECULAR GENETIC ANALYSIS OF ABO BLOOD GROUP VARIATIONS REVEALS 29 NOVEL ABO SUBGROUP ALLELES
MOLECULAR BASIS FOR JAPANESE INDIVIDUALS WITH Bm AND Am
DISRUPTION OF A BINDING SITE FOR THE ERYTHROID TRANSCRIPTION FACTOR GATA-1 IN INTRON 1 OF THE ABO GENE IN AM AND BM SUBGROUP SAMPLES
MECHANISMS OF ANTI-TUMOR T CELL THERAPY FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION
IMAGING IMMUNITY
3C-S23-03
WHOLE BLOOD AS AN ALTERNATIVE FOR COMPONENT TRANSFUSION?
LYOPHILIZED PLASMA AND FRESH FROZEN PLASMA ARE EQUALLY EFFECTIVE IN CORRECTING IMPAIRED PLASMATIC COAGULATION
EVALUATION OF DIFFERENT STORAGE POLICIES OF THAWED FRESH FROZEN PLASMA
QUANTITATIVE ANALYSIS OF PROTEINS IN FRESH FROZEN PLASMA OBTAINED FROM WHOLE BLOOD DONATIONS AND PREPARED WITH THREE PHOTOCHEMICAL TREATMENTS
IDENTIFICATION OF GLYCOSYLATION SITES IN PLASMA DERIVED ADAMTS13 EMPLOYING TANDEM MASS SPECTROMETRY
AN AMPLIFICATION ASSAY FOR THE PRESYMPTOMATIC DETECTION OF PRION IN BLOOD
SELF-DISCLOSED TEST SEEKING AND HIV EXPOSURE RISK AMONG BLOOD DONORS IN BRAZIL
LOW PREVALENCE OF NON-COMPLIANCE TO THE CURRENT 12 MONTH DEFERRAL FOR MALE-TO-MALE SEX IN AUSTRALIA
LOW PERCEPTION OF THE RISK OF HIV INFECTION AMONG REPEAT AND FIRST-TIME BLOOD DONORS IN ITALY
ANALYSIS OF RISK BEHAVIORS IN HIV POSITIVE BLOOD DONORS IN A PORTUGUESE HOSPITAL BLOOD CENTER
DONOR MOTIVATIONAL FACTORS PREDICTING DONOR RETURN AFTER MALARIA RISK TRAVEL DEFERRAL: AN APPLICATION OF PATH ANALYSIS
INTRAVENOUS IRON TO TREAT POSTOPERATIVE ANAEMIA
LIBERAL VS RESTRICTIVE TRANSFUSION THRESHOLDS FOR PATIENTS WITH SYMPTOMATIC CORONARY ARTERY DISEASE
PREDICTING RED BLOOD CELL TRANSFUSION IN HOSPITALIZED PATIENTS USING ELECTRONIC MEDICAL RECORDS
EXTENSIVE TYPING OF BLOOD DONORS FOR THE MANAGEMENT OF PEDIATRIC ERYTHROCYTE AND/OR PLATELET TRANSFUSIONS
A 13-YEAR EXPERIENCE IN THE MANAGEMENT OF PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA IN NORTHERN ISRAEL: A CLEAR COST EFFECTIVE BENEFIT FOR RITUXIMAB USE IN REFRACTORY AND RELAPSED DISEASE
INCREASED PERIOPERATIVE USE OF BLOOD PRODUCTS IS RELATED TO POOR OUTCOME POST LIVER TRANSPLANTATION
MULTIPLE PLAYERS IN B CELL MEMORY
3D-S28-02
3D-S28-03
3D-S29-01
APPROPRIATE CLINICAL USE OF BLOOD IN UGANDA
CHALLENGES FOR DEVELOPING SUSTAINABLE BLOOD TRANSFUSION SERVICES IN THE CARIBBEAN
3D-S31-01
DONOR-DEPENDENT EFFECT IN STORED PLATELET CONCENTRATES: DETERMINATION OF THROMBO ELASTOGRAPHIC RESPONSIVENESS
IN VITRO EVALUATION OF BUFFY COAT DERIVED PLATELET CONCENTRATES RESUSPENDED IN 80% OR 85% PAS IV
THE EFFECT OF MIRASOL PATHOGEN REDUCTION TREATMENT (PRT) ON THE FUNCTION OF PLATELET CONCENTRATE TRANSFUSION PRODUCTS
QUANTIFICATION OF PLATELET GROWTH FACTORS IN PLATELET CONCENTRATES PRODUCED BY DISCONTINUOUS CELL SEPARATION AND THEIR CORRELATION WITH DONOR VARIABLES
PREVALENCE OF HBV INFECTION IN SIX GEOGRAPHICAL REGIONS AND CLINICAL SENSITIVITY OF HBSAG AND HBV-DNA SCREENING
ENHANCED DETECTION OF WINDOW PERIOD AND OCCULT HEPATITIS B INFECTION BY THE ULTRIO PLUS ASSAY IN DONOR SAMPLES WITH VARYING HBV-DNA CONCENTRATIONS
CMV SEROPREVALENCE, SEROCONVERSION AND PRIMARY CMV INFECTION IN THE IRISH DONOR POPULATION
ASSOCIATION BETWEEN ABO AND D/RHESUS BLOOD GROUPS AND WNV DISEASE OUTCOME IN BLOOD DONORS: BLOOD GROUP A AND D/RHESUS-NEGATIVITY AS NEW RISK FACTORS FOR SYMPTOMATIC INFECTION
MOLECULAR, VIROLOGICAL AND PHYLOGENETIC CHARACTERIZATION OF DENGUE VIRUS TYPES 1 AND 4 INFECTING BLOOD DONORS FROM PUERTO RICO, 2012
FREQUENT HEPATITIS E VIRUS INFECTION IN DUTCH BLOOD DONORS
THE ROLE OF BLOOD TRANSFUSION IN SICKLE CELL DISEASE
4A-S33-02
HAEMOGLOBINOPATHIES: GENETIC AND CLINICAL ASPECTS WITH AN IMPACT ON BLOOD TRANSFUSION
4A-S34-01
COMPREHENSIVE GENOTYPING FOR 18 BLOOD GROUP SYSTEMS USING MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA)
NEXT-GENERATION SEQUENCING (NGS) FOR BLOOD GROUP GENOTYPING
VALIDATION OF KEL (KELL), SLC14A1 (KIDD) AND DARC (DUFFY) MALDI-TOF MS HIGH THROUGHPUT BLOOD GROUP GENOTYPING USING >3.100 SEROLOGICALLY PRE-TYPED DONOR SAMPLES
VALIDATION OF A FULLY AUTOMATED PLATFORM FOR EXTENDED BLOOD GROUP GENOTYPING
CAPACITY AND WAITING TIME REDUCTION FOR BLOOD COLLECTION SITES
A MATHEMATICAL MODEL OF RED BLOOD CELL (RBC) CLINICAL DEMAND DESIGNED TO ASSESS THE IMPACT OF RESTRICTION POLICIES FOR RBC TRANSFUSIONS
RED CELL INVENTORY FRAMEWORK FOR THE AUSTRALIAN BLOOD SECTOR
LEGISLATIVE REFORMS OF THE BLOOD TRANSFUSION SYSTEM IN PAKISTAN
A STUDY OF KNOWLEDGE AND AWARENESS OF NURSES REGARDING BLOOD TRANSFUSION SERVICES AND PRACTICES IN A TERTIARY CARE TEACHING HOSPITAL
CONSENT FOR BLOOD TRANSFUSIONS - ARE WE MAKING PROGRESS?
BLOOD DONOR PROFILING
BLOOD COLLECTION AND DONOR MOTIVATION IN GERMANY
BLOOD COLLECTION MANAGEMENT IN ROMANIAN TRANSFUSION NETWORK; CURRENT AND PERSPECTIVE FEATURES
4B-PL
BLOOD DONATION: RECRUITING DONOR CARERS WHO CAN CARE FOR BLOOD DONORS
PROBLEMS AND PROSPECTS FOR FUTURE DEVELOPMENT OF BLOOD SERVICES OF KYRGYZSTAN
BLOOD SAFETY IMPROVEMENTS AFTER CENTRALISATION AND CHALLENGES DURING THE PROCESS
A ‘TWO-TIER’ SITUATION IN THE BLOOD TRANSFUSION SYSTEM IN BURKINA FASO: IT IS URGENT TO ENSURE AN EQUITABLE ACCESS TO SAFE BLOOD PRODUCTS FOR PATIENTS
ORGANIZATION OF THE INSTITUTE FOR TRANSFUSION MEDICINE OF REPUBLIC OF SRPSKA
HISTORICAL EVOLUTION OF NATIONAL BLOOD BANK REGULATIONS IN BRAZIL
THE DETERMINANT OF SUCCESS OF MARKETING AND COMMUNICATION INSTRUMENTS: THE CASE OF BLOOD DONORS ASSOCIATION IN ITALY
ANALYSIS OF EXISTING MANAGEMENT INFORMATION SYSTEMS IN BLOOD ESTABLISHMENTS IN PAKISTAN
CYBERTRACK ELECTRONIC TRANSFUSION MONITORING
P-010
REAL-TIME MONITORING OF THE QUALITY OF THE PERFORMANCE AND ANTICIPATION OF SYSTEM TECHNICAL SERVICES FAILURES: DESCRIPTION OF A PATENTED TECHNOLOGY
FEASIBILITY OF BLOOD BANK DATA MANAGEMENT SYSTEM (BDMS) IN RECORD KEEPING AND PREVENTION OF NEAR MISS EVENTS: AN EXPERIENCE FROM RESOURCE LIMITED COUNTRY
EFFECT OF DONOR MEDICATION-DEFERRAL INFORMATION INQUIRY SYSTEM IN KOREA
VALIDATION OF AN AUTOMATED SEARCH TOOL FOR PROVIDING MATCHED DONORS FOR PATIENTS WITH PLATELET REFRACTORINESS
BLOOD COMPONENT EFFICIENCY - MAKING THE MOST OF EVERY DONATION
CONSOLIDATION OF BLOOD PROCESSING AND TESTING FACILITIES IN AUSTRALIA
LEAN SIX SIGMA PROJECT ON HOW TO MINIMIZE PAPER/ TRANSCRIPTION/DOCUMENTATION WORK FOR AUDIT TRAIL WITHIN & BETWEEN SECTIONS
EUROBLOODPACK COLLABORATIVE EVALUATION
EUROBLOODPACK COLLABORATIVE PROCUREMENT
IS LONG TERM SURVIVAL AFTER TRANSFUSION GENERALLY MORE DEPENDENT ON AGE OR ON DISEASE OF THE TRANSFUSION RECIPIENT?
REQUIREMENT FOR A BLOOD TRANSFUSION LABORATORY KNOWLEDGE BASED COMPETENCY ASSESSMENT SCHEME IN THE UK
NEW ROLE FOR BLOOD CENTERS: A FORMAL EDUCATION PROGRAM FOR TRANSFUSION SPECIALISTS IN THE UNITED STATES
THE DEVELOPMENT OF AN ON-LINE LEARNING PROGRAM FOR TRANSFUSION MEDICINE AT A TERTIARY CARE PEDIATRIC HOSPITAL
POINT OF CARE COAGULATION AND PLATELET FUNCTION TESTING: IMPLEMENTATION OF A NEW SERVICE IN A TERTIARY CARDIAC SURGERY UNIT
TEACHING MONKEYS TO WRITE - IMPROVING BLOOD TRANSFUSION RELATED DOCUMENTATION
RELATIONSHIP BETWEEN OMEGA-3 FATTY ACIDS AND TNF-? IN PATIENTS AWAITING HEART TRANSPLANTATION
SIMULATION BASED RISK ASSESSMENT TO REDUCE BLOOD TRANSFUSION ERRORS
P-028
P-029
INSPECTIONS OF BLOOD ESTABLISHMENTS IN THE POLISH BLOOD TRANSFUSION SERVICE (2009-2012): ANALYSIS OF POST-CONTROL RECOMMENDATIONS
PROCESS MAPPING IN INTRAOPERATIVE RED BLOOD CELL SALVAGE
PROFILES OF TRANSFUSION RECIPIENTS-II (PROTON-II)
TRA.DAT.E. (TRANSFUSION DATA IN ORTHOPAEDIC ELECTION) STUDY: MULTIDISCIPLINARY APPROACH FOR ELECTIVE ORTHOPAEDIC PATIENTS
EPIDEMIOLOGY OF BLOOD COMPONENT UTILIZATION IN TWO ADULT AND ONE PEDIATRIC HOSPITALS
PATIENTS BLOOD MANAGEMENT IN PEDIATRIC HOSPITAL
CONSUMPTION TREND OF BLOOD AND BLOOD COMPONENT IN AMIR ALMOMNIN HOSPITAL FROM SEPTEMBERS TO NOVEMBER 2012
MONITORING APPROPRIATE USE OF BLOOD COMPONENTS IN THE TRANSFUSION MEDICINE DEPARTMENT IN TRIESTE: SUGGESTIONS FOR IMPROVEMENT
UTILIZATION OF BLOOD COMPONENTS - PROBLEM OF WASTE AND THE AVAILABILITY OF BLOOD PRODUCTS
P-039
TIME AND TEMPERATURE INDICATOR LABELS FOR PACKED RED BLOOD CELLS - A PILOT STUDY
TRANSITION TO A NEW MAJOR BLOOD PROCESSING AND TESTING CENTRE - THE MELBOURNE EXPERIENCE
REAL TIME MANAGEMENT OF A LARGE BLOOD COMPONENT PRODUCTION NETWORK AT HEMOSC FOUNDATION USING COMPOVISION SYSTEM
BLOOD SUPPLY MANAGEMENT - REGIONAL BLOOD CENTRE EXPERIENCE
OPTIMIZATION OF PREPARING PLATELETS (IMPROVING OUTDATING PROJECT); CENTRE OF TRANSFUSION MEDICINE, UNIVERSITY CLINICAL CENTRE MARIBOR, SLOVENIA
THE IMPACT OF DONOR SELECTION ON BLOOD SAFETY IN IRAN
IMPROVE ACCURACY IN THE REPORTING OF SINGAPORE BLOOD INVENTORY USING LEAN SIX SIGMA
EXPERIENCE OF PNEUMATIC TUBE SYSTEM (PTS) FOR TRANSPORTATION OF BLOOD AND BLOOD COMPONENTS AT A TERTIARY CARE REFERRAL ONCOLOGY CENTRE
NON-CONFORMITY REPORTING SYSTEM
COMPARISION OF MICROPARTICLES BETWEEN APHERESIS AND POOLED PLATELET CONCENTRATES
CONSENT FOR BLOOD TRANSFUSION - ARE WE INFORMING PATIENTS?
AN OVERVIEW ON PERFORMANCE MONITORING USING CONTROL CHARTS AT MANSOURA REGIONAL BLOOD TRANSFUSION CENTER IN 2012, EGYPT
P-052
MAJOR CHALLENGES IN SETTING UP OF NAT LAB IN A BLOOD BANK IN RESOURCE LIMITED COUNTRIES WITH HIGH SERO PREVALENCE OF HBV, HCV AND HIV: A ROOT CAUSE ANALYSIS
ERA OF BLOOD COMPONENT THERAPY: TIME FOR MANDATORY PRE-DONATION PLATELET COUNT FOR MAXIMIZING DONOR SAFETY AND OPTIMIZING QUALITY OF PLATELETS
P-055
NON-INVASIVE PH MONITORING OF PLATELET CONCENTRATES
SUPPLY OF RECOVERED PLASMA FROM BRAZILIAN BLOOD CENTERS: AN EFFORT TO INCREASE PLASMA AVAILABILITY FOR INDUSTRIAL FRACTIONATION PLASMA
PROCESSING AND QUALITY INDICATORS FOR THE USE OF PLATELET CONCENTRATES IN THE INSTITUTE OF TRANSFUSION MEDICINE SKOPJE, R.MACEDONIA
STUDY OF FACTORS AFFECTING ON LIFETIME OF LINERS OF BLOOD BANK REFRIGERATED CENTRIFUGE
PROCESSING DATA USED TO ENSURE PROPER TRAINING OF NEW STAFF
KEY PERFORMANCE INDICATORS FOR AN SOP SYSTEM
NATIONAL PROGRAMS’ IMPLEMENTATION RESULTS IN THE TAJIK BLOOD SERVICE
THREE YEARS OF EXPERIENCE WITH A QUALITY MANAGEMENT DMS
HOW CAN ‘BLOOD’ COLLECTION AGENCIES FACILITATE FIRST TIME PLASMAPAHERESIS DONATION?
DYNAMICS OF THE VOLUNTARY ANTI-D PLASMADONOR COHORT IN THE NETHERLANDS
UP TO DATE CONCEPT OF THE BLOOD DONATION CULTURE DEVELOPMENT - ACTIVITIES OF THE BLOOD TRANSFUSION INSTITUTE OF SERBIA IN 2012
BLOOD DONATION WITHIN THE FAMILY: THE TRANSMISSION OF VALUES AND PRACTICES
ROLE OF WOMEN AND CHILDREN IN BLOOD DONATION MOVEMENT-A SUCCESS STORY
ATTITUDES TOWARDS BLOOD DONATION AND MOTIVATION TO DONATE BLOOD AMONG YOUTH IN A VOCATIONAL TRAINING INSTITUTE IN SRI LANKA
EVOLVING STRATEGIES TO ENCOURAGE REPEAT BLOOD DONATIONS IN FIRST TIME VOLUNTARY AND REPLACEMENT BLOOD DONORS IN GHANA
THE ATTITUDE OF BLOOD DONORS REGARDING INCENTIVES
DONOR RETURN RATES AFTER A POSITIVE FEEDBACK: HOW ALTRUISTIC ARE WE?
THE DEFERRED BLOOD DONOR - RISING LIKE THE PHOENIX
FIVE YEARS’ EXPERIENCE IN RECRUITING REPEAT BLOOD DONORS BY PRESENTING THEM WITH BIRTHDAY SOUVENIRS
STRATEGIES FOR INCREASING BLOOD SAFETY LEVEL: DONOR SELECTION VIEWPOINTS
IMPROVING DONOR SATISFACTION IN A PLASMAPHERESIS CENTER WITH SIX SIGMA
AVIS AND NATIONAL CIVIL SERVICE'S PLASMA AND HEALTH PROJECT
ANALYSIS OF NEW MARKETTING STRATERGIES TO IMPROVE VOLUNTARY BLOOD COLLECTION IN SOUTHERN REGION OF SRI LANKA
THE REASONS OF ABANDONING VOLUNTARY BLOOD DONATION
THE RESPONSE OF DIFFERENT ETHNIC GROUPS TO THE SAME MOTIVATIONAL TOOLS IN A MULTIETHNIC COMMUNITY
RECRUITMENT OF YOUNG BLOOD DONORS IN OSLO, NORWAY, USING SOCIAL MEDIA AS A MARKETING TOOL
YOUNG DONORS: A POTENTIAL TO GIVE RISE
MOTIVATIONAL DIFFERENCES BETWEEN STEM CELL DONORS AND REGULAR BLOOD DONORS
FACE-TO-FACE OR OVER THE PHONE: THE MEANS FOR SUCCESSFUL CONVERSION CONVERSATIONS TO PLASMAPHERESIS
THE PHYSIOLOGICAL, PRE-STORAGE VARIABILITY IN THE DONATED BLOOD AMONG MEN ELIGIBLE DONORS
IMPACT OF DEMOGRAPHIC BACKGROUND ON DONATION SUCCESS AT FIRST PRESENTATION TO THE AMERICAN RED CROSS
MINORITIES AND THE BLOOD SUPPLY: THE MISSING MINORITIES OR MIMI-PROJECT
SIMILARITIES AND DIFFERENCES BETWEEN 16 AND 18 YEAR-OLD BLOOD DONORS
A RANDOMIZED CONTROL TRIAL TO INCREASE RETURN BEHAVIOR OF FIRST-TIME DONORS USING IMPLEMENTATION INTENTION AND COMMITMENT TECHNIQUES
ETHICAL AND CULTURAL CONCERNS FOR HEALTH PROFESSIONALS, MEDIA AND THE PUBLIC IN PROMOTING ADEQUATE AND SAFE BLOOD TRANSFUSION SERVICES IN AFRICA: A CASE STUDY OF GHANA
DONOR ENGAGEMENT AT THE AUSTRALIAN RED CROSS BLOOD SERVICE
THE EVALUATION OF BLOOD DONOR DEFERRAL CAUSES IN ZIMBABWE
A REVIEW FOR TWENTY-YEAR BLOOD DONATION IN SHENZHEN, CHINA
BLOOD DONOR RECRUITMENT AT VILA CENTRAL HOSPITAL BLOOD BANK, PORT VILA, VANUATU
BLOOD AND TRANSPLANT CONSOLIDATION - REGIONAL CENTRE PRELIMINARY COLLECTION EXPERIENCE
SOCIO-DEMOGRAPHIC PROFILE OF BLOOD DONORS AT THE DEPARTMENT OF TRANSFUSION MEDICINE - STRUMICA, REPUBLIC OF MACEDONIA
STUDY ON THE CHARACTERS OF FREQUENT VOLUNTARY BLOOD DONORS IN WUHAN CITY IN CHINA AND FACTORS AFFECTING THEIR DONATION
THE NEW ROLE OF TRANSFUSIONAL MEDICINE IN THE EUROPEAN YEAR OF AGING
EVALUATION OF BLOOD DONATION IN THE PERIOD BETWEEN 2006 AND 2011
CORPORATIVE DONOR'S ACTIVITY AS THE BASIC RESOURCE FOR ADEQUATE HAEMOTRANSFUSION SUPPORT IN MEGALOPOLIS
BLOOD DONORS CHARACTERISTICS DURING THE LAST FIVE YEARS AT CASTORIA GENERAL HOSPITAL, GREECE
REASONS FOR POSSIBLE BLOOD DONORS DEFERRAL - COMPARATIVE STUY BETWEEN INHOSPITAL AND OUT OF HOSPITAL BLOOD COLLECTION
ARE THE BLOOD DONATION REPRESENTED EQUALLY AT ALL MACEDONIAN REGIONS?
ASSESSMENT OF MOTIVATING AND DEMOTIVATING FACTORS OF VOLUNTARY BLOOD DONATION AMONG THE STUDENTS OF KHARTOUM STATE UNIVERSITIES (NOVEMBER, 2009 - MAY, 2010)
BLOOD DONATION IN RUSSIAN FEDERATION
TRANSFUSION MEDICINE IN THE WORLD
FACTORS INFLUENCING BLOOD DONATION BEHAVIOR AT GLOBAL LEVEL
COMPARATIVE STUDY OF THE REASONS BLOOD UNITS WERE REJECTED BETWEEN UNITS COLLECTED IN THE HOSPITAL AND UNITS COLLECTED OUT OF IT
STATUS OF BLOOD TRANSFUSION SERVICES IN THE STATE OF UTTARAKHAND WITH SPECIAL EMPHASIS ON VOLUNTARY BLOOD DONATION
BLOOD DONATION IN THE BLOOD TRANSFUSION INSTITUTE OF SERBIA - CURRENT APPROACH AND PLANS FOR THE FUTURE
P-111
EVALUATION OF THE BLOOD DONOR'S PROFILE
STRUCTURE OF DONORS IN THE REGIONAL CENTER TETOVO
SAFETY OF VNRBDS VERSUS FAMILY REPLACEMENT BLOOD DONORS IN EGYPT, EVIDENCE BASED APPROACH
SCREENING ADOLESCENT BLOOD DONORS FOR HBA1C
PLATELET REFERENCE VALUES FOR HEALTHY IRANIAN BLOOD DONORS
P-117
USER EVALUATION OF THE NORWEGIAN BLOOD DONOR QUESTIONNAIRE
EVALUATION OF THE CONFIDENTIAL UNIT EXCLUSION PROGRAM IN YAZD BLOOD TRANSFUSION CENTER, IRAN
AN ANALYSIS OF BLOOD DONOR INFORMED CONSENT FOR FUTURE USE OF SAMPLES COLLECTED DURING A TRANSFUSION-TRANSMITTED INFECTIOUS DISEASE STUDY IN TWO BLOOD BANKS IN BRAZIL
IRON STATUS AND THE RISK FOR CARDIOVASCULAR DESEASE IN REPEATED BLOOD DONORS
IS THERE A CORRELATION BETWEEN REDUCED VALUES OF MORPHOLOGICAL PARAMETERS IN PERIPHERAL BLOOD, OF IRON METABOLISM AND BLOOD DONORS' DIET?
COMPLETE BLOOD COUNT (CBC): TIMELY INVESTIGATION IN BLOOD DONORS SCREENING
EARLY DETECTION OF METABOLIC SYNDROME IN BLOOD DONORS
DETECTION OF ANEMIA BY NON-INVASIVE HEMOGLOBIN SENSOR
DEFERRAL RATE DUE TO ANEMIA IN ABU DHABI BLOOD DONORS
STUDY OF BIOLOGICAL PARAMETERS OF THE BLOOD DONORS OF THE BLOOD TRANSFUSION CENTER MOHAMED BENABADJI
BLOOD DONATION: BENEFICIAL EFFECT ON THE HEALTH OF THE DONOR?
STUDY OF HEREDITARY IRON DEFICIENCY IN BLOOD DONORS
FREQUENT BLOOD DONATION REDUCES CARDIOMETABOLIC RISK
P-131
NONINVASIVE AND INVASIVE POINT-OF-CARE HEMOGLOBIN TESTING FOR BLOOD DONOR QUALIFICATION
COMPARISON OF TWO DIFFERENT METHODS FOR HEMOGLOBIN SCREENING IN BLOOD DONORS
FIELD TRIAL FOR A NON-INVASIVE HB-DETECTION METHOD
NON-INVASIVE STRATEGY FOR HAEMOGLOBIN SCREENING IN BLOOD DONORS
BIOFILM-FORMING SKIN FLORA BACTERIA ARE RESISTANT TO THE KILLING ACTION OF DONOR SKIN DISINFECTION
EVALUATLON OF THE USE OF AN ELECTRIC HEATING PAD DURING APHERESIS WITH THE TRIMA SYSTEM
RESULTS OF AN EDUCATIONAL PROGRAM TO PROMOTE THE USE OF APHERESIS IN THE HOSPITALS OF REGION CAMPANIA
FEASIBILITY AND SAFETY OF GRANULOCYTE APHERESIS AFTER G-CSF STIMULATION: A GERMAN MULTICENTER TRIAL
FIRST RESULTS FROM THE STUDY ON INTENSIVE PLASMAPHERESIS II (SIPLA II)
PROLONGED INTRAVASAL FLUID DEFICITS IN PLATELETPHERESIS DONORS
PLASMA ONLY COLLECTIONS - NEW POSSIBILITIES OF USING TRIMA ACCEL
ERYTHROCYTAPHERESIS ON HAEMONETICS MCS PLUS FOR PREOPERATIVE AUTOLOGOUS DONATION
OPTIMIZATION OF THE PLATELET APHERESIS PROCEDURE BY USING ACTUAL DONOR HEMATOCRIT AND PLATELET COUNT
EVALUATION OF HEMOCUE 301 IN A BLOOD COLLECTION ENVIRONMENT
COMPLIANCE OF DONORS TO PRODUCTIVE PLASMAPHERESIS PERFORMED BY NIGALE NGL XJC 2000
P-147
TRAVEL BEHAVIOUR AND DEFERRAL OF DUTCH BLOOD DONORS
COMPARISON OF DONOR DEFERRAL REASONS BETWEEN REGIONAL BLOOD TRANSFUSION CENTRE AND HOSPITAL BLOOD BANK IN ONE YEAR, A CASE STUDY IN MANSOURA REGIONAL TRANSFUSION CENTER IN DAKAHLIA, EGYPT
MULTIFACTORIAL DEPENDENCY AND EVALUATION OF HEMOGLOBIN, DETERMINED BY NON-INVASIVE AND INVASIVE MEASUREMENT IN BLOOD DONORS
DEMOGRPHIC PATTERNS OF BLOOD DONORS AND DONATIONS IN SOUTH AFRICA
P-152
ADVERSE EVENTS OF TRANSFUSION IN A TEACHING HOSPITAL IN GHANA
P-154
IMPROVING DONOR SAFETY - DELAYED DONOR ADVERSE REACTIONS
AN INVENTORY OF DEFERRALS BY DONOR-PHYSICIANS OF DUTCH DONORS THAT RESULTED IN REFERRALS TO THE DONOR'S GENERAL PRACTIONERS
ONE YEAR EXPERIENCE AFTER IMPLEMENTATION OF DONOR VIGILANCE SYSTEM AT UNIVERSITY HOSPITAL, JEDDAH
SURVEY STUDY OF HAZARDS OF BLOOD DONATION (DONOR ADVERSE EVENTS) BLOOD TRANSFUSION CENTER SAIDA ALGERIA DR AZIZA HAMMADI M.D. CESSM BLOOD TRANSFUSION MEDECINE
A RETROSPECTIVE STUDY OF ADVERSE REACTIONS AND IMPACT ON SUBSEQUENT BEHAVIOR IN BLOOD DONORS: CONTRIBUTORY ROLE OF AGE, GENDER, WEIGHT, DONOR STATUS AND COLLECTION SITES
PAST NEGATIVE EXPERIENCES WITH HIV TESTING PREDICTS TEST-SEEKING MOTIVATION AMONG BLOOD DONORS, SAO PAULO, BRAZIL
NEUROPATHIC PAIN IN DONORS WITH LONG-TERM POST DONATION MORBIDITY
IS THE DURATION OF THE PHLEBOTOMY RELATED TO THE OCCURRENCE OF VASOVAGAL REACTIONS IN REGULAR DONORS
PREDICTORS OF IRON STORE LEVELS IN DANISH BLOOD DONORS: DIETARY INTAKE AND BLOOD DONATION HISTORY - RESEARCH FROM THE DANISH BLOOD DONOR STUDY
HOW MANY BLOOD DONORS ARE COLLECTED IN AN ANAEMIC STATE?
EXTERNAL VALIDATION AND UPDATING OF A DUTCH PREDICTION MODEL FOR LOW HEMOGLOBIN DEFERRAL IN IRISH WHOLE BLOOD DONORS
IMPACT OF INFORMING WHOLE BLOOD DONORS OF LOW FERRITIN RESULTS
ROLE OF IRON SUPPLEMENTATION IN PREVENTION OF IRON DEFICIENCY IN REGULAR BLOOD DONORS: RANDOMISED, PLACEBO CONTROLLED STUDY
A SIGNIFICANT LOST: DEFERRED DONORS BY LOW HEMOGLOBIN LEVELS
VOLUNTARY BLOOD DONORS WITH ANEMIA
BONE DENSITY IN FREQUENT APHERESIS DONORS COMPARED TO WHOLE BLOOD DONORS
THE RESULTS OF SCREENING WHOLE BLOOD AND PLASMA DONORS FOR IMMUNOGLOBULIN A DEFICIENCY IN THE NETHERLANDS
USE OF FROZEN RED BLOOD CELL UNITS IN FINLAND
HAEMOGLOBIN S SCREENING IN LOMBARDY RARE DONOR PROGRAM AND MANAGEMENT IN OUR BLOOD TRANSFUSION CENTER
DEVELOPMENT OF A NOVEL DEVICE TO IMPROVE WHOLE BLOOD COOLING AND STORAGE AT MOBILE COLLECTIONS AND DURING TRANSPORTATION TO THE PROCESSING CENTER
P-175
QUALITY ASSESSMENT OF BLOOD PRODUCTS PREPARED USING HOLLOW-FIBRE SEPARATION SYSTEM
THE CHANGES OF PHOSPHOLIPIDS IN AUTOLOGOUS WHOLE BLOOD PRODUCTS BY THE PRE-STORAGE LEUKOREDUCTION
QUALITY CONTROL DATA FOR MPS UNDER ROUTINE CONDITIONS
IMPROVEMENT OF EFFICIENCY OF BLOOD COMPONENTS PRODUCTION USING THE REVEOS AUTOMATED BLOOD PROCESSING SYSTEM
QUALITY CONTROL RESULTS OF BLOOD COMPONENTS PRODUCED WITH AN AUTOMATED PROCESS, ATREUS©3C IN A BLOOD BANK OF A CENTRAL HOSPITAL
EVALUATION OF BLOOD COMPONENT PRODUCTION WITH THE FULL AUTOMATED TACSI WB SYSTEM AND SUBSEQUENT MIRASOL®PRT TREATMENT OF PLATELET CONCENTRATES
BLOOD COMPONENTS PREPARED BY A NEW AUTOMATED BLOOD COMPONENT SEPARATOR
USABILITY STUDY ON A NEW AUTOMATED BLOOD COMPONENT SEPARATOR
EVALUATION OF NEW WHOLE BLOOD SEPARATORS WITH AUTOMATED BAG OPENING MECHANISM: COMPOMAT G5 - MACOPRESSE
IN-VITRO QUALITY OF RED BLOOD CELLS, POOLED PLATELET CONCENTRATES, AND PLASMA PRODUCTS PREPARED FROM OVERNIGHT STORED WHOLE BLOOD BY AUTOMATED BLOOD COMPONENT PROCESSING MACHINE TACSI
NEW APPROACH OF WHOLE-BLOOD SEPARATION WITH TACSI WB SYSTEM TERUMO BCT: RED BLOOD CELL CONCENTRATE CONSERVATION STUDY
WHOLE-BLOOD SEPARATION INTO BLOOD COMPONENTS WITH NOVEL TACSI WB SYSTEM: FIRST EVALUATION IN ROUTINE PRODUCTION
STORAGE OF PLATELETS RESUSPENDED IN PLATELET ADDITIVE SOLUTION (PAS) CONTAINING GLUCOSE AND BICARBONATE
MULTICENTER EVALUATION OF A NEW PLATELET ADDITIVE SOLUTION CONTAINING GLUCOSE: INTERSOL-GTM
IN VITRO QUALITY OF DOUBLE PLATELET CONCENTRATES IN PLASMA AND ADDITIVE SOLUTION USING THE UNIVERSAL PLATELET PROGRAM (UPP TM) OF THE MCS®+
IN VITRO PROPERTIES OF HYPER-CONCENTRATED PLATELETS DURING 7-DAY STORAGE IN M-SOL ADDITIVE SOLUTION
IN VITRO EVALUATION OF LEUKOCYTE-DEPLETED BUFFY COAT POOLED PLATELET CONCENTRATES SUSPENDED IN AN ADDITIVE SOLUTION OF FOURTH GENERATION, INTERSOL-G
EFFECT ON APHERESIS PLATELET CONCENTRATES AFTER MAXIMAL PLASMA REMOVAL AND REPLACING WITH PAS 5: A COMPARISON FROM TWO DIFFERENT APHERESIS COLLECTION DEVICES
CLOT FORMING CAPACITY AND STORAGE STABILITY OF PLATELETS AFTER UVC PATHOGEN INACTIVATION
MIRASOL PATHOGEN REDUCTION TECHNOLOGY MODULATES PLATELET OXIDATIVE STRESS
P-196
CLINICAL EFFICACY OF PLATELET CONCENTRATES TREATED WITH THE INTERCEPTTM BLOOD SYSTEM
THE EFFICACY OF UVC PATHOGEN INACTIVATION ON THE REDUCTION OF PLASMODIUM FALCIPARUM IN BUFFY COAT DERIVED PLATELETS
THE EFFICACY OF UVC PATHOGEN INACTIVATION ON THE REDUCTION OF BABESIA DIVERGENS IN BUFFY COAT DERIVED PLATELETS
INFLUENZA A VIRUS H3N2 IS EFFICIENTLY INACTIVATED BY THE THERAFLEX UV-PLATELETS SYSTEM
THE BLUEFLEX FILTER OF THE THERAFLEX MB-PLASMA SYSTEM (MACOPHARMA) EFFICIENTLY ELIMINATES DIFFERENT BACTERIA SPECIES FROM THERAPEUTIC PLASMA
THE EFFECT OF VOLUME ON PLATELET QUALITY DURING STORAGE AFTER UV-C TREATMENT
EVALUATION OF MAUAL POOLING OF 8 BUFFY-COATS FOR DOUBLE-DOSESPOOLED PATHOGEN-REDUCED PLATELET CONCENTRATES
P-204
THE FUNCTIONAL PROPERTIES OF PLATELETS TREATED WITH THE INTERCEPT BLOOD SYSTEM FOR PATHOGEN INACTIVATION
EFFECT OF INTERCEPTTM BLOOD SYSTEM TECHNOLOGY ON THE QUALITY OF PLATELET CONCENTRATES - EXPERIENCE FROM MOSCOW HAEMATOLOGY RESEARCH CENTER
PATHOGEN REDUCTION TECHNOLOGY TREATMENT OF TACSI PLATELETS IN PLASMA
IN VITRO QUALITY OF PLATELETS TREATED IN THE THERAFLEX UV-PLATELETS SYSTEM IS WELL PRESERVED DURING STORAGE
P-209
QUALITY ASSESSMENT OF POOLED LEUCO-DEPLETED PLATELETS PATHOGEN REDUCED BY RIBOFLAVIN, USING THE MIRASOL TECHNOLOGY
AUTOMATIC BLOOD PROCESSING OF PLATELET CONCENTRATES FROM TOP AND BOTTOM BLOOD BAGS - STANDARD PROCEDURE AND GOOD QUALITY CONTROL
EFFECTIVE METHOD OF DOUBLE DOSE BUFFY-COAT PLATELET CONCENTRATES PREPARATION
USAGE OF SDPS VS PRPS IN BANDUNG BLOOD TRANSFUSION SERVICE IN 2012
EFFECT OF STORING WHOLE BLOOD AT 22 ± 2? FOR 24 H PRIOR TO BLOOD COMPONENT SEPARATION WITH THE BUFFY COAT METHOD ON ACTIVATION OF PLATELET CONCENTRATES AND ACTIVITY OF COAGULATION FACTORS IN PLASMA
P-215
WASHING OF PLATELETS BY USING COBE 2991
STANDARDIZATION OF THE QUALITY OF BUFFY-COAT PREPARED PLATELET CONCENTRATES USING TOP AND BOTTOM BLOOD BAGS
PLATELET PRODUCTION VERSUS WASTAGE AT THE NITM - SKOPJE
ONE STEP AUTOMATED ROUTINE PRODUCTION OF PLATELET CONCENTRATES. A TWO YEARS EXPERIENCE IN TWO FRENCH REGIONAL CENTERS: CRITICAL POINTS ON ORGANIZATION AND PRODUCTIVITY IMPACT
THE EFFECT OF HOLDING TIME OF WHOLE BLOOD, BUFFY COAT, AND/OR BUFFY COAT POOL ON THE QUALITY OF PLATELET CONCENTRATES
EXPERIENCE OF BUFFY COAT POOLING OF PLATELETS AS A SUPPORTIVE CARE IN THROMBOCYTOPENIA IN DENGUE PATIENTS- A PROSPECTIVE STUDY
A NOVEL AND SIMPLE STRATEGY TO IMPLEMENT QUALITY CONTROL SAMPLING PLANS FOR LABILE BLOOD PRODUCTS AT THE ETABLISSEMENT FRANCAIS DU SANG
COMPARISON OF QUALITY CONTROL PARAMETERS OF LEUKODEPLETED PLATELET CONCENTRATES OBTAINED WITH DIFFERENT METHODS
MACHINE-RELATED LEUKOCYTE CONTAMINATION IN PLATELET APHAERESIS
CORRELATION OF THE HYPOTONIC SHOCK RESPONSE AND EXCHANGE OF SHAPE CHANGE WITH THE NEW THROMBOLUX®
THE INFLUENCE OF FOUR DIFFERENT ANTICOGULANTS ON PLATELET QUALITY TESTING WITH THROMBOLUX®
OCCURRENCE OF RESIDUAL AGGREGATES IN SINGLE DONOR PLATELET CONCENTRATES IN ROUTINE BLOOD BANKING
COMPARISON OF PLATELET FUNCTION AND PLASTICIZER AMOUNT OF TOTM AND DEHP PVC BLOOD BAGS
RANDOM OCCURRENCE OF AGGREGATES IN NEWLY PRODUCED PLATELET UNITS ARE RELATED TO HIGHER ACTIVATION AND ACCUMULATED RELEASE OF THE IMMUNOMODULATORY FACTORS SCD40 L AND RANTES
STORAGE OF PLATELET POOLS PREPARED BY SEMIAUTOMATED AND FULLY AUTOMATED SYSTEMS
PLATELET CONCENTRATES STORED WITHOUT AGITATION FOR 6 H AT 18°C
INFLUENCE OF LENGTH OF STORAGE OF CRYOPRESERVED RED BLOOD CELLS ON THE QUALITY AND EFFECTIVENESS OF TRANSFUSIONS
RED CELL APHERESIS WITH AUTOMATED IN-LINE FILTRATION
VALIDATION OF THE S-303 PATHOGEN INACTIVATION SYSTEM FOR RBC COMPONENTS
PRESERVED MORPHOLOGY AND METABOLIC PROPERTIES OF STORED RED BLOOD CELL CONCENTRATES PREPARED WITH S-303 PATHOGEN INACTIVATION PROCESS
QUALIFICATION OF THE S-303 TREATMENT SYSTEM AT TWO ITALIAN BLOOD CENTERS
PREPARATION OF LEUKODEPLETED RBC UNITS AFTER AN OVERNIGHT HOLD OF WHOLE BLOOD AT ROOM TEMPERATURE USING A TOP AND BOTTOM BAG SYSTEM WITH AN INTEGRAL IN-LINE WBC FLEXIBLE FILTER
EVALUATION OF QUALITY PARAMETRES OF LEUKOREDUCED RED BLOOD CELL CONCENTRATE USING DIFFERENT TYPES OF LEUKOREDUCTION SYSTEMS
EVALUATION OF DIFFERENT TYPES OF LEUKODEPLETION USED IN EGYPTIAN BLOOD TRANSFUSION SERVICES
HEMOLYSIS OF RED CELL CONCENTRATES AT THE END OF STORAGE
COMPARATIVE EVALUATION OF HEMOLYSIS PARAMETERS BETWEEN G6PD DEFICIENT BLOOD DONORS AND HEALTHY DONORS DURING BLOOD STORAGE IN BLOOD BANK CONDITION
IN VITRO QUALITY OF RED BLOOD CELLS FROM UNDERWEIGHT WHOLE BLOOD COLLECTIONS OF 300 TO 350 ML
PLASMA COMPOSITION EFFECTS ON MECHANICAL FRAGILITY OF PACKED RED BLOOD CELLS
THE OVINE PACKED RED BLOOD CELL STORAGE LESION: CHARACTERISATION AND COMPARISON TO THAT OF HUMAN PACKED RED BLOOD CELLS
MEASURING DEFORMATION OF RED BLOOD CELLS (RBCS) OVER STORAGE USING A LUMIFUGE® ANALYSER
THE EFFECT OF STORAGE ON RED BLOOD CELL DEFORMABILITY: A MICROFLUIDIC APPROACH
COMPARISON OF MICROPARTICLE PRODUCTION IN PACKED RED BLOOD CELLS STORED UNDER ANAEROBIC AND CONVENTIONAL COLD STORAGE CONDITIONS
IMPROVED STORAGE OF WEEKLY MIXED RED CELL UNITS IS ATTRIBUTABLE TO ENHANCED PLASTICIZER MIGRATION
ALTERNATION IN ERYTHROCYTE SUPEROXIDE DISMUTASE AND GLUTATHIONE PEROXIDASE ENZYME ACTIVITIES DURING STORAGE OF BLOOD
QUALITY OF INACTIVATED RED CELLS COMPARED TO GAMMA IRRADIATED RED CELLS
EFFECT OF ATP LEVEL AND MEMBRANE STABILIZER ON RBC STORAGE: COMPARISON OF TWO TYPES OF SOLUTIONS
THE INFLAMMATORY PROPERTY OF RED BLOOD CELL CONCENTRATES DURING COLLECTION, PROCESSING AND STORAGE
HEMOLYSIS AND SUBLETHAL INJURY IN RED BLOOD CELLS STORED IN A NOVEL ADDITIVE SOLUTION
USE OF PLASMA COMPONENTS IN CLINICAL HOSPITAL STIP
AUDITING OF USAGE/WASTAGE OF FRESH FROZEN PLASMA AT UNIVERSITY HOSPITAL, JEDDAH, SAUDI ARABIA
QUALITY CONTROL OF FIBRINOGEN CONCENTRATE FROM PLASMA TREATED IN MIRASOL® PATHOGEN REDUCTION TECHNOLOGY
VALIDATION OF THE QUALITY CONTROL OF FRESH FROZEN PLASMA FOLLOWING THE EFFECT OF RIBOFLAVIN AND ULTRAVIOLET LIGHT USING PRT SYSTEM
RIBOFLAVIN AND UV-LIGHT TREATED PLASMA IN VITRO QUALITY EVALUATION
PATOGEN INACTIVATION OF INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS BY PASTEURIZATION IN IMMUNOGLOBULIN SOLUTION
INACTIVATION OF CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS (CCHFV) IN FULL UNITS OF HUMAN PLASMA USING AMOTOSALEN AND UVA
SCREENING OF PATIENTS FOR PREEXISTING ANTIBODIES TO PATHOGEN INACTIVATED RED BLOOD CELLS
EFS IMPLEMENTS RADIO FREQUENCY IDENTIFICATION (RFID) WITH PLASMA FOR LFB GROUP
QUALITY OF CRYOPRECIPITATE MANUFACTURED FROM FRESH FROZEN PLASMA TREATED WITH METHYLENE BLUE OR INTERCEPT PATHOGEN INACTIVATION SYSTEMS
HUMAN PLASMA PROTEIN SOLUTION PREPARATION BY ETHANOL
IMMUNOGLOBULIN A PREPARATION BY ION EXCHANGE CHROMATOGRAPHY
AN ATTEMPT TO IMPROVE FACTOR VIII LEVELS IN CRYOPRECIPITATE USING LEAN SIX SIGMA TOOLS
AUTOMATED WEIGHING, LABELLING AND RELAEASE OF HUMAN PLASMA
USING HOLLW FIBER CARTRIDGE FOR THE PREPARATION OF ALBUMIN AS A BIOLOGICAL DRUG
THE EVALUATION OF PLASMA QUALITY STORAGE WITH PVC BLOOD BAG AND NON-PVC BLOOD BAG
SUPPLY AND QUALITY OF BLOOD PRODUCTS FROM VOJVODINA BLOOD TRANSFUSION INSTITUTE, SERBIA
THE AUTOMATIZATION IN GRANULOCYTE COLLECTION USING THE OPTIA DEVICE EASES THE PROCEDURE AND PROVIDES CONCENTRATES OF HIGH QUALITY
STUDY OF ENVIRONMENTAL CONDITIONS ON BLOOD BANK REFRIGERATORS PERFORMANCE AT IRANIAN BLOOD TRANSFUSION CENTERS
ELONGATING THE CLOTTING TIME OF CRYOLIJM-SQ
INFUSIBLE PLATELET MEMBRANES IMPROVE HEMOSTASIS IN THROMBOCYTOPENIC RABBITS: STUDIES WITH TWO DIFFERENT INJECTION DOSES
VOLUMETRIC RESTITUTION BY PLATELET GEL IN CONSERVATIVE SURGICAL BREAST CANCER TREATMENT
ANTIPHOSPHOLIPID SYNDROME AND FAMILIAL THROMBOPHILIA- CASE REPORT IGIC M. NIKOLIC B. BLOOD TRANSFUSION CENTRE PIROT, SERBIA BLOOD TRANSFUSION INSTITUTE NIS, SERBIA
THE FIRST ATTEMPT TO EVALUATE A PREVALENCE AND INCIDENCE OF INFECTIONS AMONG BLOOD DONORS IN RUSSIA
CHANGES IN FREQUENCY OF HBV, HCV, HIV AND SYPHLIS INFECTIONS WHICH REMOVED FROM BLOOD SUPPLY IN TEHRAN BLOOD DONATIONS 2005-2010
NUCLEIC ACID TESTING FOR BLOOD BANKS: AN EXPERIENCE FROM A TERTIARY CARE CENTRE IN NEW DELHI, INDIA
ASSOCIATION OF ABO AND RH BLOOD GROUPS TO BLOODBORNE INFECTIONS AMONG BLOOD DONORS IN TEHRANIRAN
PREVALENCE OF TRANSFUSION TRANSMITTED INFECTIOUS DISEASES MARKERS IN MACEDONIAN BLOOD DONORS
P-283
NEW VIRAL SCREENING APPROACH BASED ON ULTRASENSITIVE POLYTHIOLATED PROBES
HEPATITIS B AND C VIRUS INFECTIONS AMONG PATIENTS WITH HEPATIC CIRRHOSIS
ESTIMATION OF INCIDENCE AND RESIDUAL RISK OF HIV, HBV AND HCV INFECTIONS AMONG BLOOD DONORS IN TEHRAN - A SURVEY
USED? HE STANDARDS AND PROCEDURES FOR DECREASING THE NUMBER OF HBSAG AND ANTI-HCV-AB POSITIVE BLOOD UNITS FROM VOLUNTAY BLOOD DONORS BETWEEN 2002 AND 2012 - EVALUATION OF THE RESULTS
EXPERIENCES WITH THE COBAS TAQSCREEN DPX-TEST ON TO COBAS S201 INSTRUMENT FOR DETECTION OF PARVOVIRUS B19, AND HAV INFECTIONS IN BLOOD DONATIONS
ADDITIONAL DENGUE TESTING HELPS IN PREVENTION TRANSFUSION TRANSMITED INFECTIONS -EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN NORTH INDIA
EVALUATION OF 6 YEARS OF CONFIDENTIAL UNIT EXCLUSION AT THE BELGIAN RED CROSS FLANDERS: WASTE OR VALUE?
MONITORING OF LOT - DEPENDED DIFFERENCES IN SPECIFICITY OF SEROLOGICAL SCREENING TESTS (PRISM/ ABBOTT) FOR EARLY INTERVENTION IN CASE OF VARIATIONS
ACTIVE AND LATENT HERPES VIRUSES IN BLOOD AND BONE MARROW DONORS
THE TRACKING AND RE-TEST OF TEMPORARY SHIELED UNQUALIFIED BLOOD DONORS AND ITS SIGNIFICANCE
THE INFLUENCE NAT TESTING ON THE BLOOD TRANSFUSION SAFETY IN THE OPERATING AREA REGIONAL BLOOD CENTRE AND BLOOD TREATMENT IN KATOWICE IN YEARS 2006-2012
NRL EQAS: OBSERVATIONS FROM THE NAT BLOOD SCREENING PROGRAM 2012
NAT SCREENING FOR HIV-1, HCV AND HBV IN BLOOD DONATIONS AT THE NATIONAL BLOOD CENTRE AND REGIONAL BLOOD CENTRES OF THE THAI RED CROSS SOCIETY IN 2008 TO 2012
RESULTS OF THE POSTDONATION INTERVIEW WITH BLOOD DONORS POSITIVE AFTER SCREENING OF TTI
SEROLOGICAL SCREENING FOR CORNEA TRANSPLANTATION
EVOLUTION OF RESIDUAL RISK FOR HIV, HCV AND HBV FROM 1991 TO 2010, IN BLOOD DONATIONS OF THE CENTRO HOSPITALAR S. JOÃO, EPE, PORTO, PORTUGAL
WHAT IS THE MOST EFFICIENT ALGORITHM FOR INDIVIDUAL DONATION NUCLEIC ACID TESTING (ID-NAT)?
ANALYSIS OF HIV HCV AND HBV SIEROVIROLOGICAL POSITIVENESS AMONG THE BLOOD DONORS OF THE LAZIO REGION AND THE SOUTH PART OF TUSCANY
CHALLENGES IN BLOOD ESTABLISHMENTS - HOW TO CORRECTLY VALIDATE THE SCREENING TESTS ON VIRAL MARKERS AND TREPONEMA PALLIDUM OF BLOOD DONORS
PERFORMANCE CHARACTERISTICS OF THE PROCLEIX WEST NILE VIRUS (WNV) ASSAY ON THE FULLY AUTOMATED PROCLEIX PANTHER SYSTEM AND COMPARISON TO PERFORMANCE ON THE TIGRIS SYSTEM
P-304
EVOLVING TESTING PROTOCOLS FOR HBV-SEROLOGY YIELD CASES - OUR EXPERIENCE
TTI REACTIVE BLOOD DONOR NOTIFICATION AND COUNSELLING: OUR EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA
PREDICTION OF REAL TIME PCR DETECTION LIMITS ON VIRAL GENOTYPE REFERENCE PANELS BY COMPARING CYCLE TRESHOLD (CT) VALUES
EVALUATION OF THE ROCHE COBAS® TAQSCREEN DPX TEST FOR PARVOVIRUS B19 DNA GENOTYPES DETECTION IN BLOOD DONORS
NOTIFYING BLOOD DONORS OF INFECTION: HOW WELL ARE WE DOING?
EXPERIENCE WITH LEVEY JENNINGS CHART AS A MONITORING TOOL FOR QUALITY CONTROL OF EIA TESTING
INDIVIDUAL DONOR NAT TESTING USING THE COBAS S201 SYSTEM: 4 YEARS EXPERIENCE IN A MOLECULAR BLOOD TRANSFUSION CENTER
EQUIVALENT ANALYTICAL SENSITIVITY OF THREE TRIPLEX TRANSCRIPTION MEDIATED AMPLIFICATION (TMA) ASSAY VERSIONS
SCREENING IN DEFERRED BLOOD DONORS WITH RISK FACTORS TO SEXUAL TRANSMITTED INFECTIONS
SEROLOGICAL CONFIRMATION OF HTLV-1 AND 2 BY IMMUNOBLOT IN BLOOD DONORS: A RETROSPECTIVE STUDY
THE PREVALENCE OF HIV, HBV, HCV, AND SYPHILIS INFECTIONS AMONG BLOOD DONORS AT BLOOD BANK MEKELLE, TIGRAY, ETHIOPIA
ANTIVIRAL IMMUNITY AND RESISTANCE OR SUSCEPTIBILITY TO HBV INFECTION RELATE TO THE BALANCE BETWEEN TREG FREQUENCY AND PD-1 CD4+ EXPRESSION: PREVIOUS RESULTS
MINI-POOLING OF THE DONOR PLASMA SAMPLES CAN NOT PROVIDE THE HEPATITIS B AND C SAFETY OF BLOOD TRANSFUSION
PREVALENCE OF ANTI-HBS IN THE POPULATION OF YOUNG DONORS UNIVERSALLY VACCINATED FOR HBV
KIR AND SPECIFIC HLA-C GENE ARE ASSOCIATED WITH OCCULT HBV INFECTION AND SPONTANEOUS HBV CLEARANCE IN BLOOD DONORS WITH ANTI-HBC-ONLY PROFILE
EVALUATION OF ARCHITECT HBSAG QUALITATIVE II ASSAY COMPARED WITH ARCHITECT HBSAG QUALITATIVE ASSAY FOR BLOOD DONATION SCREENING
SURVAY OF THE HEPATITIS B VIRUS PREVALENCE IN BLOOD DONORS IN FARS BLOOD TRANSFUSION ORGANIZATION IN 2005-2011
COMPARISON OF BLOOD DONATION SCREENING TESTS FOR HEPATITIS B VIRUS INFECTIONS IN CHONGQING, CHINA
OCCULT HEPATITIS B IN REGULAR DONORS SCREENED SEVERAL TIMES BY ID-NAT IN CATALONIA, SPAIN
SENSITIVITY OF THE ULTRIO AND ULTRIO PLUS ASSAY VERSIONS IN DETECTING WINDOW PERIOD AND OCCULT HEPATITIS B INFECTION IN POLISH BLOOD DONORS
EPIDEMIOLOGICAL AND MOLECULAR ASPECTS OF OCCULT HEPATITIS B IN GREECE
HCV SERO-CONVERSION IN HCV NEGATIVE RECIPIENTS OF ALLOGENIC HSCT
CO-PREVALENCE OF HEPATITIS C IN HIV SERO-POSITIVE INTENDED BLOOD DONORS IN KATHMANDU, NEPAL
TEN YEARS EXPERIENCE IN DETERMINATION OF POSITIVE ANTI-HCV BLOOD DONATIONS IN SOUTHWESTERN GREECE
EVALUATION STUDY OF COBAS AMPLIPREP/COBAS TAQMAN HCV QUANTITATIVE TEST, V.2.0 ON COBAS AMPLIPREP/COBAS TAQMAN DOCKING STATION
P-330
HCV TRANSMISSION RISK AND EFFICACY OF SCREENING STRATEGIES ESTIMATED FROM DATA PROVIDED BY AN INTERNATIONAL NAT STUDY GROUP
P-332
NEW STRATEGIES FOR THE SCREENING OF HEPATITIS C VIRUS INFECTION
RECOMMMENDATION OF A NEW CONFIRMATORY ALGORITHM AND SIGNAL-TO-CUTOFF RATIO FOR HCV TESTING OF DONATED BLOOD
TREND OF HEPATITIS C AMONG SHIRAZ BLOOD TRANSFUSION SERVICE (7 YEARS EXPERIENCE)
RISK FACTORS FOR INFECTION AMONG RECENTLY HCV INFECTED BLOOD DONORS IN POLAND
RISK FACTORS FOR HEPATITIS C VIRUS INFECTION IN IRANIAN BLOOD DONORS
EPIDEMIOLOGY OF HEPATITIS B AND C VIRUS AMONG MILITARY BLOOD DONORS
A CASE OF HIV INFECTION IN A BLOOD DONOR DETECTED DURING SEROCONVERSION
INTERDONATION INTERVALS OF SEROCONVERTORS AND IMPACT ON BLOOD SAFETY IN ZIMBABWE
MULTICENTER STUDY OF A NEW HIGHLY SENSITIVE AND SPECIFIC HIV ANTIGEN/ANTIBODY COMBO ASSAY, ENZYGNOST HIV INTEGRAL 4
A NEW INNOVATIVE AMPLIFIED CHEMILUMINESCENT BIOCHIP TECHNOLOGY FOR BLOOD VIRUS SEROLOGY
EVALUATION OF GEENIUSTM HIV 1/2 CONFIRMATORY ASSAY - CE
CYTOKINES ARE INDICATORS OF PROGRESSING OF A HIVINFECTION IN CHILDREN
HIV-2 SURVEILLANCE AMONGST SOUTH AFRICAN BLOOD DONORS
SURVEILLANCE OF HIV INFECTION IN THE GENERAL POPULATION AND IN BLOOD DONORS IN GREECE: THE IMPACT OF ECONOMIC CRISIS ON RISK BEHAVIOURS
DIAGNOSTIC UTILITY OF ELISA, CHEMILUMINESCENCE AND HEMAGGLUTINATION FOR SCREENING TREPONEMA PALLIDUM IN DONORS
EVALUATION OF A RAPID TREPONEMAL TEST TO HELP THE BLOOD DONOR COUSELLING
VALIDATION OF RAPID BACTERIAL DETECTION IN PLATELET CONCENTRATES
EFFICIENCY OF THE BACTX® ASSAY SYSTEM TO DETECT BACTERIAL CLINICAL ISOLATES IN BUFFY COAT PLATELET CONCENTRATES
THROMBOLUX PLATELET SCREENING FOR QUALITY CONTROL AND BACTERIAL DETECTION
CO-PRESENCE OF ANTIBODIES TO TREPONEMA PALLIDUM AND MARKERS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN SEROLOGICAL SCREENING OF BLOOD DONORS
EXTERNAL QUALITY ASSURANCE PROGRAMME FOR BACTERIAL DETECTION IN PLATELETS
EVALUATION OF THE SITUATION OF SYPHILIS INFECTION IN OUR DONOR POPULATION
TREATMENT OF PLATELET PRODUCTS WITH RIBOFLAVIN AND UV LIGHT: EFFECTIVENESS AGAINST HIGH TITER BACTERIAL CONTAMINATION
SYPHILIS TESTING AND CROSS REACTIONS FOR SYPHILIS IN GHANAIAN BLOOD DONORS
THE NUMBER OF TREPONEMA PALLIDUM (TP) INFECTIONS AMONG THE BLOOD DONORS OF THE REGIONAL BLOOD CENTRE IN POZNAN
SIX YEARS OF SEROLOGICAL PLASMODIUM SPP. ANTIBODY SCREENING IN SWISS BLOOD DONORS
ALTERED AVIDITY OF A AND B ANTIGENS AND ANTIBODIES IN FALCIPARUM PLASMODIASIS
IS 12 MONTHS DEFERRAL OF DONORS WHO VISITED MALARIA ENDEMIC AREAS SUITABLE FOR ALL COUNTRIES WHO ARE NOT ENDEMIC FOR MALARIA?
SERO-EPIDEMIOLOGY OF SYPHILIS INFECTIONS AMONG BLOOD DONORS IN CHINA
SEROPREVALENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 1 (HTLV-1) INFECTION IN BETA-THALASSEMIA MAJOR PATIENTS OF QOM PROVINCE, CENTRAL IRAN
THE PREVALENCE OF HEPATITIS B, HEPATITIS C VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS AT PREGNANT WOMEN AND AT PERSON WITH RISKY BEHAVIOUR
HEPATITIS E SEROPREVALENCE AMONG BLOOD DONORS- A PILOT STUDY FROM WESTERN INDIA
GENE POLYMORPHISMS OF OXIDATIVE STRESS ENZYMES IN CHAGASIC PATIENTS
RE-MERGING INFECTIONS IN TRANSFUSION THERAPY: A MONITORING PROJECT IN CAMPANIA REGION, SOUTH ITALY
IS ALZHEIMER'S DISEASE A PRION DISEASE?
DENGUE OUTBREAK IN MADEIRA ISLAND (PORTUGAL) BLOOD SAFETY MEASURES
ESTIMATING THE TRANSFUSION TRANSMISSION RISKS OF Q FEVER IN THE NETHERLANDS
EVALUATION OF NEW AUTOMATED TPHA ASSAY FOR BLOOD DONOR'S SCREENING
SHORT ANALYTICAL VERIFICATION OF ARTUS CMV RG PCR KIT ON QIACUBE/ROTOR- GENE Q/6000 SYSTEM
ARTUS EBV RG PCR KIT ON QIACUBE/ROTOR- GENE Q/6000 SYSTEM- SHORT ANALYTICAL VERIFICATION
FIRST INTERNATIONAL PROFICIENCY PANEL FOR HEPATITIS E VIRUS DETECTION
P-375
INVESTIGATIONAL DENGUE TESTING YIELDS HIGH RATES OF RNA-POSITIVE DONORS IN PUERTO RICO
SEROPREVALENCE OF CYTOMEGALOVIRUS INFECTION AMONG BLOOD DONORS IN WESTERN INDIA
PRIORITIZING EMERGING PATHOGENS IN TRANSFUSION SAFETY THROUGH EXPERT ELICITATION
PRIORITISATION OF ARTHROPOD-BORNE DISEASES AS URGENT THREATS FOR TRANSMISSION THROUGH SUBSTANCES OF HUMAN ORIGIN IN EUROPEAN UNION
ABO BLOOD GROUP DISTRIBUTION AND SUSCEPTIBILITY TO CHIKUNGUNYA INFECTION DURING THAILAND: ANALYSIS FROM DIFFERENT TYPES OF CONTROL SELECTION
RISK ASSESSMENT MODELS FOR VARIANT CREUTZFELDT-JAKOB DISEASE (VCJD) TRANSMISSION VIA RED BLOOD CELLS
REMOVAL OF EXOGENOUS PRION INFECTIVITY IN LEUCOREDUCED RED BLOOD CELLS UNIT BY P-CAPTTM PRION REMOVAL FILTER
UPDATE ON THE ABILITY OF THE PRION CAPTURE FILTER, P-CAPT™, TO DELAY ONSET OF AN ORIGINAL MYELOPATHIC DISEASE OBSERVED IN PRIMATES EXPOSED TO PRION INFECTED BLOOD PRODUCTS
CONTAMINATED BLOOD PRODUCTS INDUCE AN ATYPICAL PRION DISEASE IN PRIMATES IN THE ABSENCE OF DETECTABLE ABNORMAL PRION PROTEIN
P-385
P-386
PREVALENCE OF FOURTEEN BLOOD GROUP SYSTEMS IN KOREAN POPULATION: PHENOTYPE PREDICTION FROM GENOTYPE ANALYSIS
FREQUENCY OF DUFFY GENE POLYMORPHISM IN POLISH POPULATION STUDIED BY HIGH RESOLUTION MELTING (HRM) ANALYSIS
HETEROGENEITY OF ALLELES ENCODING HIGH- AND LOWPREVALENCE ANTIGENS ACROSS AFRICA: A USEFUL DATA TO SUPPORT TRANSFUSION IN AFRICAN PATIENTS
RH ANTIGEN AND PHENOTYPE FREQUENCY AMONG BLOOD DONORS IN CENTRAL SAUDI ARABIA
DISTRIBUTION OF ABO AND RH D BLOOD GROUPS AMONG BLOOD DONORS OF JAMMU REGION WITH RESPECT TO VARIOUS ETHNIC GROUPS
RH GENOTYPES AMONG MALAYSIAN BLOOD DONORS
HIGH AND LOW FREQUENCY ALLELES IN SICKLE CELL DISEASE (SCD) PATIENTS OF A MIXED POPULATION
EXTENDED RED BLOOD CELL PHENOTYPING IN THE NETHERLANDS
EXTENDED RED CELL ANTIGEN PHENOTYPING OF BLOOD DONORS: RESOURCE-LIMITED COUNTRY'S PERSPECTIVE
RED BLOOD CELL EXTENDED PHENOTYPE MATCHING IN PATIENTS UNDERGOING CHRONIC TRANSFUSION: EVALUATION OF DONOR AVAILABILITY
RED BLOOD CELLS TRANSFUSION, WHICH ARE IDENTICAL IN 10 ANTIGENS
DEVELOPING NATIONAL POLICIES FOR RED CELL SEROLOGICAL TESTING IN CLINICAL PRACTICE
AUTOMATION IN IMMUNOHEMATOLOGY LAB: AN EVALUATION OF QWALYS 3 IN A TERTIARY CARE CENTRE IN INDIA
REPRODUCIBILITY STUDY OF GALILEO ECHO INSTRUMENT IN TWO DIFFERENT BLOOD BANK ENVIRONMENTS
CORRELATION BETWEEN TWO DIFFERENT METHODS TO EVALUATE WEAK D VARIANTS
COMPARATION OF CONVENTIONAL TUBE METHOD WITH GEL COLUMN METHOD FOR ANTI-A/B TITRATION
AUTOMATION OF THE POLYBRENE TECHNIQUE WITH ACT ROBOT FULLY AUTOMATIC SPIN TUBE SYSTEM
EVALUATION OF IMMUCOR NEO® PERFORMANCE IN A BIG BLOOD DONOR CENTER‘S ROUTINE FROM BRAZIL
EVALUATION OF QWALYS3 FOR ABO/D GROUPING AND IRREGULAR ANTIBODY SCREENING TEST
RED CELL ANTIBODIES IN BLOOD DONORS DETECTED BY STANDARD TUBE TEST AND A MICROCOLUMN GEL AGGLUTINATION: A COMPARATIVE STUDY FOR SAFE BLOOD TRANSFUSION
PREVALENCE OF IRREGULAR RED CELL ANTIBODIES IN BLOOD DONORS
PREVALENCE OF IRREGULAR ANTIBODIES IN DONOR POPULATION IN NORTH INDIA FROM A TERTIARY CARE HOSPITAL
FREQUENCE OF ALLOIMMUNIZZATION IN BLOOD DONORS OF TRASFUSION SERVICE OF ASL CASERTA
DONOR BLOOD TESTING - ANTIBODY SCREENING USING THE INDIRECT ANTIGLOBULIN TEST
THE POSSIBILITY OF CHANGING ALGORITHM FOR CONFIRMATORY IMMUNOHEMATOLOGICAL TESTING BY INDIRECT ANTIGLOBULIN TEST IN CROATIAN BLOOD DONORS
ALGORITHM FOR REENTRY OF CROATIAN BLOOD DONORS WITH POSITIVE DIRECT ANTIGLOBULIN TEST
INTRODUCTION OF PRE TRANSFUSION PHENOTYPING AND ANTIBODY SCREENING OF BOTH PATIENTS AND DONORS IN INDIA AS AN EFFECTIVE SUPPORT TOOL FOR BLOOD TRANSFUSION
EXTERNAL QUALITY ASSESSMENT IN BLOOD GROUP TESTING IN CHINESE TRANSFUSION LABORATORY IN 2012
IMPLEMENTATION OF A NATIONAL QC SYSTEM FOR RED CELL SEROLOGY IN EGYPTIAN NBTS
LOW TITER INTERNAL QUALITY CONTROL (WEAK ANTI-D) FOR TESTING PERFORMANCE OF AUTOMATED RED BLOOD CELL ANTIBODY SCREENING
POLISH EXTERNAL QUALITY ASSESSMENT PROGRAM FOR TRANSFUSION IMMUNOHEMATOLOGY LABS - ANALYSIS OF ABO AND COMPATIBILITY RESULTS IN ‘PATIENTS’ WITH A MIXED POPULATION OF RED BLOOD CELLS
STUDY FOR THE STANDARDIZATION OF ABO ANTIBODY TITER AT THE LABORATORIES IN KOREA
EXTENSION OF DURABILITY OF 0.8% SCREENING CELLS IN THE BLOOD TYPING INSTRUMENT BY USING PIERCEABLE CAPS
A METHOD FOR EXTENDED SEROLOGICAL ANTIGEN TYPING AND DNA TESTING OF DONORS LEADING TO BETTER INFORMATION ON ERYTHROCYTE PANELS
ROLE OF PANELS, TECHNIQUES AND CLINICAL DATA IN ANTIBODY IDENTIFICATION
PANEL USAGE IN ANTIBODY IDENTIFICATION - CONSIDERATION OF RATIONAL STRATEGY
IN 40% GLYCEROL FROZEN RED BLOOD CELLS (RBCS) MAINTAIN THEIR ANTIGENIC PROFILES AND REMAIN USEFUL FOR DIAGNOSTIC PURPOSES
P-424
DETERMINATION OF ABH ANTIGENS BY IMMUNOHISTOCHEMISTRY IN BREAST CANCER PATIENTS
RED CELL ANTIBODY DETECTION IN PATIENTS WHO REQUEST BLOOD AT TERTIARY CARE HOSPITAL, BANGKOK, THAILAND
DETECTION OF IRREGULAR ANTIBODIES AGAINST RBCS IN PRETRANSFUSION TESTING IN AN UNIVERSITY HOSPITAL FROM 2004 TO 2012
DETERMINATION OF THE CLINICAL SIGNIFICANCE OF ANTIBODY SPECIFICITIES TO M, N AND LEWIS BLOOD GROUP SYSTEM
THE INCIDENCE OF ANTIBODIES TO RED BLOOD CELL ANTIGENES IN HEMATOPOIETIC CELLS RECIPIENTS: AN ANALYSIS OF CASES FROM THE PERIOD OF FIVE YEARS BASED ON RESEARCH OF RECIPIENTS
ALLOIMMUNIZATION: CASE REPORT
MULTIPLE RED CELL ANTIBODIES - A CASE STUDY
A PATIENT WITH MULTIPLE RED CELL ALLO-ANTIBODIES WITH EXTREME DIFFICULTY TO FIND COMPATIBLE BLOOD
DETECTION OF ANTI-LUTHERAN 7: A CASE REPORT
AN UNEXPECTED CAUSE OF AN UNEXPECTED POSITIVE CROSSMATCH RESULT
ACUTE BLEEDING IN A PATIENT WITH AN ANTI-KPB ANTIBODY: MANAGEMENT ISSUES AND CASE REPORT
P-436
P-437
ALLOIMMUNIZATION AND ERYTHROCYTE AUTOIMMUNIZATION IN TRANSFUSION DEPENDENT THALASSEMIC PATIENTS
PREVALENCE OF RED CELL ALLOIMMUNIZATION IN REPEATEDLY TRANSFUSED PATIENTS WITH?- THALASSEMIA
INCIDENCE OF RED CELL ALLOANTIBODIES UNDERLYING PANREACTIVE WARM AUTO-ANTIBODIES IN MULTITRANSFUSED EGYPTIAN PATIENTS
P-441
ERYTHROCYTE ALLOIMMUNIZATION IN MULTI-TRANSFUSED EGYPTIAN PATIENTS WITH AUTOIMMUNE HEMOLYTIC ANEMIA
HOW OFTEN DOES A POSITIVE RESULT OF A DIRECT ANTIGLOBULIN TEST (DAT) INDICATE THE PRESENCE OF WARM AUTOANTIBODIES?
IMPROVING THE PROVISION OF BLOOD FOR PATIENTS WITH AUTO-IMMUNE HAEMOLYTIC ANAEMIA
P-445
AUTO-IMMUNE HAEMOLYTIC ANAEMIA CAUSED BY A PRIMARY CYTOMEGALOVIRUS INFECTION IN AN IMMUNOCOMPETENT ADULT
AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) IN A PATIENT WITH MALARIA: A CASE REPORT
REMOVING IGG ANTIBODIES FROM RED CELLS: INTEREST AND PERFORMANCE OF THE GAMMA EGATM KIT (IMMUCOR)
A CASE OF AUTOIMMUNE HAEMOLYTIC ANAEMIA (AIHA) INVOLVING RARE AUTOANTIBODIES AGAINST JK3 AND JKB IN A PATIENT WITH EVANS SYNDROME WHO RECENTLY DELIVERED A HEALTHY BABY
THE VALUE OF IGG SUBCLASS DETERMINATION IN PATIENTS WITH A POSITIVE DIRECT ANTIGLOBULIN TEST WITH ANTI-IGG
DEVELOPMENT OF ENHANCING AGGLUTINATION REACTION USING GOLD NANOPARTICLE FOR PRETRANSFUSION TESTING
APPLICATION OF FLOW CYTOMETRY AND MICROSCOPY METHODS IN ANALYSIS OF ANTIBODY-COATED RED BLOOD CELLS PHAGOCYTOSIS
NOVEL PHAGOCYTOSIS ASSAY OF PLATELETS BY PH SENSITIVE FLUORESCENCE
LABEL FREE RBC-TYPING AND SCREENING IN A SINGLE ASSAY
VARIANT RH ALLELES AND RH IMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE
RED BLOOD CELL ALLOIMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE: A BRAZILIAN INSTITUTIONAL EXPERIENCE
ALLOANTIBODY FORMATION IN PATIENTS WITH SICKLE CELL DISEASE
MOLECULAR CHARACTERISTICS OF PARTIAL D IN KOREANS
FIRST COMPREHENSIVE INVESTIGATION OF BOTH RHD AND RHCE ALLELE DISTRIBUTION IN SUB-SAHARAN AFRICA: THE CLINICAL IMPLICATIONS FOR TRANSFUSION MEDICINE
D VII: THE MOST FREQUENT PARTIAL D IN CZECH POPULATION WITH ‘HIDDEN ICEBERG’ REAL INCIDENCE: RESULTS OF A PROFICIENCY SURVEY AND D VARIANT DATABASE IN UHKT
BEING POSITIVE CAN BE NEGATIVE - IDENTIFICATION OF A PARTIAL DIIIC
A NOVEL RHCE ALLELE IDENTIFIED IN CHINESE DONORS
ANTI-D IN PATIENTS EXPRESSING WEAK D TYPE 2
RHD*WEAK D TYPE 48 IS PREVALENT IN SOUTHERN AUSTRIA
IDENTIFICATION OF 7 NOVEL RHD VARIANTS RESULTING IN PARTIAL, WEAK OR ABSENT RHD EXPRESSION
RHD ALLELES IN D-NEGATIVE PREGNANT WOMEN FROM A MULTIETHNIC POPULATION
MOLECULAR CHARACTERIZATION OF D ANTIGEN IN BLOOD DONORS SEROLOGICALLY TYPED AS D NEGATIVE AND ITS IMPACT ON INVENTORY MANAGEMENT OF D NEGATIVE BLOOD UNITS
IDENTIFICATION OF D VARIANTS IN APPARENTLY RH D NEGATIVE ANTENATAL WOMEN IN INDIA
A LONG PCR SYSTEM FOR THE INVESTIGATION OF DIFFICULT RHESUS VARIANTS
DETECTION OF WEAK ABO SUBGROUPS IN BLOOD DONORS IS ESSENTIAL FOR SAFE CLINCAL TRANSFUSION PRACTICE
ABO DISCREPANCY IN SNAKE BITE PATIENTS: AN EXPERIENCE AT TERTIARY CARE CENTRE
LIMITATIONS OF ABO CROSSMATCH TO DETECT ABO INCOMPATIBILITY
THE SIGNIFICANCE OF ISOAGGLUTININ TITER IN TRANSPLANTATION OF ABO RED CELL-INCOMPATIBLE ALLOGENIC HEMATOPOIETIC STEM CELLS
ABO INCOMPATIBLE KIDNEY TRANSPLANTATION: AN APPROACH TO STANDARDISE ANTIBODY TITRATION METHODS
DETERMINATION OF ABH ANTIGENS BY IMMUNOHISTOCHEMISTRY IN BREAST CANCER PATIENTS
BLOOD TYPE DIETS: ARE THE CLAIMED HEALTH BENEFITS FACT OR FICTION? ASYSTEMATIC REVIEW
EXPRESSION OF THE FUT2 GENE AND CD44 MARKER IN PATIENTS WITH ORAL LESIONS
SEROLOGICAL AND GENETIC ANALYSIS OF 5 INDIVIDUALS CARRYING THE BOMBAY OR PARA-BOMBAY PHENOTYPE AND IDENTIFICATION OF 2 NOVEL NON-FUNCTIONAL FUT1 ALLELES
GENETIC BASIS OF CIS-AB IN A WOMAN FROM POLAND WHERE THE PHENOTYPE WAS FIRST DESCRIBED
THE R168Q MUTATION IS ASSOCIATED WITH THE BW PHENOTYPE AND PREDICTION OF DECREASED STABILITY OF THE RESULTING GLYCOSYLTRANSFERASE
A NEW EXAMPLE OF THE RARE KEL:-37 (KHUL-) PHENOTYPE
DOMBROCK GENE ANALYSIS IN AFRICAN PEOPLE REVEALS TWO NOVEL ALLELES: DOB-I5T AND DOB-W266R
MOLECULAR IDENTIFICATION OF RARE FY*BNULL ALLELE IN YOUNG CAUCASIAN THALASSAEMIC PATIENT FROM SARDEGNA
MOLECULAR ANALYSIS OF IMMUNIZED LAN- OR JRANEGATIVE PATIENTS AND VALIDATION OF GENOTYPING ASSAYS TO SCREEN BLOOD DONORS FOR LAN- OR JRA-NEGATIVITY
GENETIC ANALYSIS OF THE JR(A-) IN JAPANESE PEOPLE
NOVEL JR NULL ALLELES IN THE JAPANESE POPULATION
THE NEW MUTATIONS OF ABCB6 GENE IN LAN- JAPANESE
IDENTIFICATION OF U- AND U+VAR PHENOTYPES IN BRAZILIANS USING MOLECULAR METHODS
THE AQP1 601DELG SEEMS TO BE THE PREVALENT MUTATION CAUSING THE CO NEGATIVE PHENOTYPE IN ROMANI PATIENTS
DEVELOPMENT OF AN AUTOMATED BLOOD GROUP GENOTYPING PLATFORM DEDICATED FOR BLOOD DONATIONS TESTING
DEVELOPMENT OF A NEW PROTOCOL TO GENOTYPE 16 ALLELES RESPONSIBLE FOR EXPRESSION OF CLINICALLY SIGNIFICANT ANTIGENS FROM RH, KELL, DUFFY, KIDD AND MNS BLOOD GROUP SYSTEMS
RAPID AND SENSITIVE TEST FOR BLOOD GROUP GENOTYPING IN MULTIPLE TRANSFUSED PATIENTS: COST AND BENEFITS
THE BIOARRAY SOLUTIONS HEA BEADCHIP: VALIDATION AND IMPLEMENTATION
A RECURRENT GYPB MUTATION (C.137-8C>T) FOUND IN SOCALLED P2 ALLELES INDUCES A GENOTYPING ERROR FOR GYPB*S
FIVE YEARS OF PROFICIENCY TESTING PROGRAM FOR MICROARRAY USERS
COMBINING SEROLOGY AND MOLECULAR TYPING OF WEAK D ROLE IN IMPROVING D TYPING STRATEGY IN EGYPT
CW/C ALLELIC DISCRIMINATION BY REAL TIME PCR USED FOR TYPING RH51(MAR) NEGATIVE DONORS
P-498
USING MULTIPLE METHODS FOR THE RESOLUTION OF DISCREPANT RESULTS IN CELLANO ANTIGEN TYPING
‘IN-HOUSE’ ASP-PCR TECHNIQUE TO DETERMINE HBS WITH NO DIRECT DNA EXTRACTION
EVALUATION OF RHD AND RHCE*C MOSAICISM/CHIMERISM BY REAL-TIME PCR IN A BLOOD DONOR WITH MIXED-FIELD AGGLUTINATION IN RH PHENOTYPING
EVALUATION OF A RHD BLOOD GROUP SYSTEM GENOTYPING TEST USING MULTIPLEX PCR
CONTRIBUTION OF EXTENDED ERYTHROCYTE GENOTYPING IN PATIENTS TO THE BLOOD TRANSFUSION SAFETY
HLA-DRB1*15 IS NOT STRONGLY LINKED TO RHD IMMUNIZATION RISK, BUT ASSOCIATED WITH HIGH ANTI-D TITERS AFTER HYPERIMMUNIZATION
HLA-DRB1*04 ALLELE AND SUSCEPTIBILITY TO RED BLOOD CELL ALLOIMMUNIZATION IN PATIENTS WITH MYELODISPLASIC SYNDROME
THE ASSOCIATION OF HLA SYSTEM POLYMORPHISMS WITH THE DEVELOPMENT OF CLINICALLY SIGNIFICANT RED BLOOD CELL ANTIBODIES
HLA-DRB1 ASSOCIATIONS IN INDIVIDUALS WITH SINGLE AND MULTIPLE RED BLOOD CELL ANTIBODIES
POST-TRANSFUSION RED BLOOD CELL ALLOIMUNIZATION INCIDENCE AFTER A FIRST SINGLE ROUTINE OR EXTENDED MATCHED TRANSFUSION EVENT
NON-INHERITED MATERNAL ANTIGENS DO NOT PREVENT MATERNAL RED BLOOD CELL AND HLA ALLOANTIBODIES IN PREGNANCIES COMPLICATED BY SEVERE HAEMOLYTIC DISEASE OF THE FETUS
ANTI-K FORMATION IS NOT ASSOCIATED WITH THE STORAGE TIME OF TRANSFUSED RED BLOOD CELLS
INFLUENCE OF DONOR'S AND RECIPIENT'S HPA COMPATIBILITY ON PLATELET RESTORATION AND NUMBER OF PLATELET TRANSFUSION AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION
RISK FACTORS OF PLATELET ALLOIMMUNIZATION
HUMAN PLATELET ANTIGEN ALLELES IN TAIWANESE BLOOD DONORS
DISTRIBUTION OF HUMAN PLATELET ANTIGENS-1 TO -6 AND -15 IN THE HONG KONG BLOOD DONOR POPULATION
HUMAN PLATELET ANTIGEN GENOTYPES AS PREDICTORS OF LIVER CIRRHOSIS IN PATIENTS WITH HCV CHRONIC INFECTION
HUMAN PLATELET ANTIGEN 3 GENOTYPE IS AN INDEPENDENT PREDICTOR OF PLATELET COUNT IN PATIENTS WITH CHRONIC HEPATITIS C
NEW CHALLENGES IN PLATELET TYPING
A NOVEL HUMAN MONOCLONAL HPA-1A-SPECIFIC ANTIBODY IS A USEFUL TOOL FOR DIAGNOSTICS IN FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
INTRODUCTION OF BLOODCHIP ID-HPA FOR HIGH THROUGHPUT MOLECULAR BIOLOGY TYPING IN A IMMUNOHEMATOLOGY LABORATORY FOR THE MANAGEMENT OF PATIENTS WITH PLATELET REFRACTORINESS, THROMBOCYTOPENIA AND FNAIT
SINGLE-ANTIGEN MAGNETIC BEAD ASSAY (SAMBA) FOR THE SENSITIVE DETECTION OF HPA-1A ALLOANTIBODIES USING TAG-ENGINEERED RECOMBINANT SOLUBLE?3 INTEGRIN
PAK LX BEAD BASED IMMUNOASSAY VS MAIPA FOR DETECTION OF PLATELET ANTIBODIES
PROSPECTIVE SCREENING FOR ANTI-PLATELET ANTIBODIES AND IMMUNE PLATELET REFRACTORINESS IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA
SEROLOGICAL COMPATIBILITY TESTS IN ALLOIMMUNIZED ONCOHEMATOLOGICAL PATIENTS BEFORE PLATELET TRANSFUSIONS: CLINICAL AND ECONOMICAL EFFECTIVENESS
P-524
TWO CASES OF ANTI-GPIV ANTIBODY MEDIATED PLATELET TRANSFUSION REFRACTORINESS
THE DETECTION OF HUMAN PLATELET ALLOANTIBODIES (HPA)-15 IN POLYTRANSFUSED PATIENTS
FREQUENCY OF ANTI-PLATELET ANTIBODIES IN PATIENTS WITH PLATELET REFRACTORINESS
CORRELATION BETWEEN HEPATITIS C AND ANTI PLATELETS ANTIBODIES
DRUG-INDUCED THROMBOCYTOPENIA
THE DIRECT MAIPA REVISITED FOR THE DETECTION OF PLATELET AUTOANTIBODIES
A NOVEL FLOW CYTOMETRY-BASED PLATELET AGGREGATION ASSAY
CHRONIC PEDIATRIC ITP PATIENTS WITH A STRONG BLEEDING TENDENCY AND LOW PLATELET COUNTS SHOW DECREASED AGGREGATION CAPACITY VIA THE GPIIBIIIA ACTIVATION ROUTE
EFFECTOR T CELLS IN CHILDREN WITH ACUTE IMMUNE THROMBOCYTOPENIA BECOME UNRESPONSIVE TO TREG MEDIATED REGULATION
C-REACTIVE PROTEIN ENHANCES ANTIBODY-MEDIATED PLATELET DESTRUCTION
THE STOCKHOLM STUDY: CONCLUSIONS AFTER 3 YEARS FETAL RHD SCREENING IN EARLY PREGNANCY
ROUTINE FETAL RHD GENOTYPING USING CELL FREE FETAL DNA: FRENCH EXPERIENCE AT THE HOSPITAL OF POISSY
IMPROVEMENT OF NON INVASIVE FETAL RHD GENOTYPING FROM MATERNAL PLASMA: DEVELOPMENT OF A MULTIPLEX PCR TEST
INTRODUCTION OF AN RHD NEGATIVE TYPE-AND-SCREEN IN PREGNANT WOMEN TREATED WITH ANTI-D PROPHYLAXIS
NON-INVASIVE PRENATAL BLOOD GROUP TYPING IN PREGNANCIES WITH KNOWN ANTIBODIES
DNA-EXTRACTION FROM CELL FREE MATERNAL PLASMA WITH THE SNAPCARDTM METHOD
PERSISTENCE OF FETAL HAEMOGLOBIN AS A CAUSE OF FALSE POSITIVE KLEIHAUER-BETKE (ACID ELUTION) TESTS AND EXCESSIVE PROPHYLACTIC ANTI-D ADMINISTRATION
ALLOIMMUNIZATION OF RH-D NEGATIVE PREGNANT WOMEN IN ALBANIA
THE INCIDENCE OF ERYTHROCYTE ALLOIMMUNIZATION IN PREGNANT WOMEN
ANTI-EMM IN A PREGNANT PATIENT
MILD HAEMOLYTIC DISEASE OF FETUS AND NEWBORN DUE TO ANTI- G AND -C
HEMOLYTIC DISEASE OF THE NEWBORN DUE TO ANTIDIEGO( B) -REVIEW OF FOUR CASES FROM ONE INSTITUTION
P-547
NEONATAL ABO INCOMPATIBILITY: LABORATORY AND CLINICAL EVALUATION
FETAL MICROCHIMERISM MAY PLAY A ROLE IN MATERNAL RED BLOOD CELL ANTIBODY PERSISTENCE
ENHANCEMENT OF ANTIBODY TITRE AND DEVELOPMENT OF ADDITIONAL RED CELL ALLOANTIBODIES FOLLOWING INTRAUTERINE TRANSFUSION
CLINICAL AND LABORATORIAL MANAGEMENT OF INTRAUTERIN TRANSFUSION (IUT)
IN VITRO FERTILIZATION: A RISK FACTOR FOR RH(D) HEMOLYTIC DISEASE OF THE NEWBORN?
NON IMMUNE HYDROPS DUE TO PARVOVIRUS B19 IN PREGNANCY: A CASE REPORT
H435-CONTAINING IGG3 ALLOTYPES ARE TRANSPORTED EFFICIENTLY ACROSS THE HUMAN PLACENTA: IMPLICATIONS FOR ALLOANTIBODY-MEDIATED DISEASES OF THE NEWBORN
COMPARISON OF THE FC GLYCOSYLATION OF FETAL AND MATERNAL IMMUNOGLOBULIN G
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAIT) - A RETROSPECTIVE ANALYSIS OF SUSPECTED FNAIT CASES STUDIED BETWEEN 2007 AND 2012 IN CENTRO HOSPITALAR SÃO JOÃO
DIAGNOSIS OF SUSPECTED CASES OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAITP) IN CENTRO DE SANGUE E TRANSPLANTAÇÃO DO PORTO (CSTP)
ARE CURRENT MURINE MODELS OF FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA BRINGING US CLOSER TO A BETTER UNDERSTANDING OF PATHOPHYSIOLOGY AND TREATMENT OF THE DISEASE?
THE INCIDENCE OF NEONATAL ALLOIMMUNE NEUTROPENIA DUE TO MATERNAL ALLOIMMUNIZATION AGAINST HUMAN NEUTROPHIL ALLOANTIGEN-3 IN THE BRAZILIAN POPULATION
AGE-DEPENDENT PATTERN OF EXPRESSION IN RBC COMPLEMENT REGULATORY PROTEINS
THE DYNAMICS OF ANTIGEN-SPECIFIC B CELLS DURING IMMUNIZATION
CONFORMATIONAL CHANGES IN MEMBRANE PROTEIN BAND 3 ASSOCIATED WITH ERYTHROCYTE AGING
TO STUDY OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY PARENT PLATELET ANTIGENS INCOMPATIBILITY IN CHINA
THE IMPACT OF TRANSFUSIONS ON MORTALITY OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
MANAGEMENT, COMPLICATIONS OF THERAPY AND OUTCOMES OF TTP IN AUSTRALIA: DATA FROM THE NATIONAL REGISTRY
A LONG-TERM REMISSION IN PATIENTS WITH RELAPSING OR REFRACTORY T.T.P. AFTER RITUXIMAB TREATMENT
CERTIFCATION OF APHERESIS NURSES: DEVELOPMENT OF AN EFFECTIVE TRAINING PROGRAM
EFFICACY AND COST EFFECTIVENESS OF THERAPEUTIC PLASMA EXCHANGE (TPE) IN CASES OF GUILLAIN-BARRE SYNDROME (GBS)
IMMEDIATE BENEFIT FROM PLASMA EXCHANGE IN THE TREATMENT OF SEVERE HYPERTRIGLYCERIDEMIA USING SPECTRA-OPTIA VS COBE-SPECTRA
SAFETY AND EFFICACY OF MINI-POOL S/D CRYOPRECIPITATE-POOR-PLASMA (S/D-CPP) IN PARTIAL VOLUME THERAPEUTIC PLASMA EXCHANGE
PRETRANSPLANT MONITORING OF PLASMAPHERESIS EFFECTS FOR DONOR SPECIFIC ANTI-HLA ANTIBODY IN A KIDNEY TRANPLANT RECIPIENT
IMMUNOADSORPTION ONTO STAPHYLOCCOCAL PROTEIN A HAS A USE FOR TRANSPLANTOLOGY
PLASMA EXCHANGE: A HOSPITAL REGISTER
P-575
THERAPEUTIC PLASMA EXCHANGE IN NEUROLOGICAL PATIENTS TREATED FROM JANUARY TO DECEMBER 2012
ROLE OF TPE IN THE ‘CARDIAC ALLOGRAFT REJECTION’: CASE REPORT
P-578
P-579
THERAPEUTIC RED CELL EXCHANGE IN MALARIA AND SICKLE CELL DISEASE
OUR EXPERIENCE IN TREATING HEREDITARY HEMOCHROMATOSIS: ERYTHROCYTAPHERESIS VS PHLEBOTOMY
MEDICATIONS AND THERAPIES AND THE OCCURRENCE OF ALLOIMMUNIZATION AGAINST RED BLOOD CELL TRANSFUSIONS
P-583
RISK OF TRANSFUSION TRANSMITTED INFECTIONS AND DEVELOPMENT OF ALLOANTIBODIES IN MULTI-TRANSFUSED THALASSEMIC PATIENTS
IN-PROCESS LEUKOCYTE DEPLETION: NEED OF MULTI-TRANSFUSED PATIENTS
SURVEY OF TRANSFUSION MEDICINE TRAINING IN THE UK
COMPARISON OF TWO APHERESIS INSTRUMENTS IN PLASMA REMOVAL EFFICIENCY DURING THERAPEUTIC PLASMA EXCHANGE RELATED TO KIDNEY TRANSPLANTATION
DEVELOPING TRANSFUSION GUIDELINES IN THE UK
IMPACT OF INTERNATIONAL ACCREDITATION IN TRANSFUSION PRACTICE AT RSUPN DR. CIPTO MANGUNKUSUMO
CLINICAL STUDY ON THE EFFECT OF REDUCING PROPHYLACTIC PLATELET TRANSFUSION DOSE ON BLEEDING IN STABLE THROMBOCYTOPENIA PATIENTS
P-590
EVALUATION OF PERCENT PLATELET RESPONSE AND CORRECTED COUNT INDEX IN CORONARY ARTERY BYPASS GRAFT (CABG) PATIENTS- STUDY AT TERTIARY CARE CARDIAC CENTRE IN INDIA
SUCCESSFUL SUPPORT OF HLA-MATCHED PLATELETS TO REFRACTORY PATIENTS WITH ELECTRONIC MATCHING
FLOWCYTOMETRIC QUANTITATION OF CIRCULATING ERTHROCYTE DERIVED AND PLATELET DERIVED MICROPARTICLES IN BETA THALASSEMIA PATIENTS: RELATION TO THROMBOEMBOLIC EVENTS
EVALUATION OF RARE RED BLOOD CELL TRANSFUSIONS
MODELS TO PREDICT BLOOD COMPONENT TRANSFUSION IN LIVING DONOR LIVER TRANSPLANTATION
P-596
P-597
THE INFLUENCE OF ABO BLOOD GROUPS ON COMPLICATIONS AFTER CARDIAC SURGERY
EFFECTS OF ‘NO’ TRANSFUSION, AUTOLOGOUS TRANSFUSION, ALLOGENIC TRANSFUSION AND AGE OF BLOOD ON OUTCOME IN CARDIAC SURGERIES
PERIOPERATIVE MONITORING OF ALLOGENEIC BLOOD TRANSFUSION IN CARDIAC SURGICAL PATIENTS: MASSIVE TRANSFUSION
SURGEON PATIENTS AND TRANSFUSION IN A KRASNODAR REGIONAL HOSPITAL
P-602
AN EXPERIENCE OF BLOOD TRANSFUSION BY DIFFERENCE OF THE COUNT OF FUSION SEGMENTS IN LUMBOSACRAL SPINAL FUSION
‘PRE-OPERATIVE IRON’ USE AS BLOOD SPARING TECHNIQUE IN ORTHOPAEDIC SURGERY (THE POP-I STUDY)
USE OF BLOOD COMPONENTS IN EAST-TALLINN CENTRAL HOSPITAL IN 2007 - 2011
USE OF BLOOD COMPONENTS IN PATIENTS BLEEDING FROM THE GASTROINTESTINAL TRACT (FOUR YEARS EXPERIENCE)
OUTPATIENT BLOOD TRANSFUSION TREATMENT
PROSPECTIVE STUDY REVEALS A RAPID INITIAL RESPONSE TO AUTOLOGOUS SERUM EYE DROPS (ASED) FOR KERATOCONJUNCTIVITIS SICCA AND NON-HEALING CORNEAL ULCERS
A PROSPECTIVE STUDY FOR QUANTIFICATION OF CYTOKINES AND GROWTH FACTORS FROM PLATELET-RICH PLASMA AND ASSESSMENT THE ROLE IN NON-HEALING CUTANEOUS ULCERS
MANAGEMENT OF A BIOLOGICAL PREPARATION (PLATELET RICH PLASMA EYE DROPS) FOR THE TREATMENT OF CHRONIC GRAFT VS HOST DISEASE: PROPERTIES AND QUALITY OF THE PRODUCT AND CLINICAL RESULTS
TISSUE PLASMINOGEN ACTIVATOR INDUCED FIBRINOLYIS ON ROTATIONAL THROMBOELASTOMETRY IN CHEMOTHERAPY INDUCED THROMBOCYTOPENIA.
A NON-RADIOACTIVE METHOD FOR THE QUANTIFICATION OF TRANSFUSED PLATELETS IN RECIPIENTS
CRITICAL BLEEDING EVENTS CAN BE CLASSIFIED USING ADMINISTRATIVE DATA FOR THE PURPOSES OF ASSIGNMENT IN A MASSIVE TRANSFUSION REGISTRY
IMPROVING TRANSFUSION SUPPORT FOR TRAUMATIC MASSIVE HAEMORRHAGE
PRELIMINARY HISTOLOGICAL EVIDENCE THAT RED CELL TRANSFUSIONS EXACERBATE LUNG INJURY IN AN OVINE ECMO MODEL
TERRORISM, TRAUMA εt TRANSFUSION - BOMB BLAST AT HIGH COURT OF DELHI, NEW DELHI, INDIA ON SEPTEMBER 7, 2011
USE OF MINIMALLY CROSS-MATCHED RED BLOOD CELLFOR EMERGENT TRANSFUSION IN A COUNTRY WITH LOWER INCIDENCD OF UNEXPECTED ANTIBODIES
MASSIVE TRANSFUSION PROTOCOL USED AT A CANADIAN TERTIARY CARE FACILITY: DESCRIPTIVE OUTCOMES AND PRODUCT USED
USE OF RECOMBINANT FACTOR VIIA (rFVIIa) IN ACUTE LIFE THREATENING PRIMARY POSTPARTUM HAEMORRHAGE: A CASE REPORT
ACQUIRED HAEMOPHILIA A - LABORATORY DIAGNOSIS AND MONITORING IN A PATIENT WITH MULTIPLE HAEMATOMAS
FIBRINOGEN DERIVATIVES IMPROVE COAGULATION PROFILES OF PATIENTS WITH HYPOFIBRINOGENEMIA DURING THE PERIOPERATIVE PERIOD REGARDLESS OF THE CONCENTRATION OF FIBRINOGEN PRODUCTS
EXPERIENCE OF FIBRINOGEN LEVELS MEASURED BY TEG FF AND ROTEM FIBTEM
FACTORS PREDICTING INTRA-OPERATIVE BLOOD TRANSFUSIONS DURING LIVER TRANSPLANTATION: STUDY FROM A SINGLE CENTER
P-624
DONOR SEX AND TRANSFUSION RECIPIENT MORTALITY-RESULTS FROM TWO HOSPITALS
FATAL TRANSFUSION-ASSOCIATED GRAFT VS HOST DISEASE (TA-GVHD) FOLLOWING EMERGENCY INTRAUTERINE TRANSFUSION OF MATERNAL BLOOD: CASE REPORT AND SURVEY OF UK PRACTICE
THROMBOTIC EVENT OCCURRENCE AMONG THE ELDERLY US MEDICARE BENEFICIARIES TRANSFUSED IN THE INPATIENT SETTING, AS RECORDED IN LARGE ADMINISTRATIVE DATABASES DURING 2007-2011
CARDIOPULMONARY BYPASS PROCEDURE INDUCES EXTRACELLULAR RED BLOOD CELL VESICLE FORMATION
TRANFUSION ADVERSE REACTIONS IN PAEDIATRICS, A 3-YEAR SURVEY
DELAYED HEMOLYTIC POSTTRANSFUSION REACTION IN CASE OF ANTI-JKB ANTIBODIES: CASE REPORT
TRANSFUSION-RELATED ACUTE LUNG INJURY (TRALI): CASE REPORT
TRANSFUSION-RELATED ACUTE LUNG INJURY IN OBSTETRIC AND GYNECOLOGICAL PRACTICE
THE INCIDENCE OF ALLERGIC REACTIONS RELATED TO FRESH FROZEN PLASMA IN FRANCE
ROUTINE USE OF MINI-POOL NUCLEIC ACID TESTING (MPNAT) MULTIPLEX ASSAY FOR SERO-NEGATIVE BLOOD DONORS
BARCODE TECHNOLOGY IMPLEMENTATION FOR PATIENT'S IDENTIFICATION IS EFFECTIVE TO PREVENT ABO WRONG TRANSFUSIONS
P-637
REVIEW OF 3 YEARS OF REPORTING TO SHOT'S WEB-BASED HAEMOVIGILANCE DATA CAPTURE SYSTEM
QUALITY INDICATORS FOR THE HOSPITAL TRANSFUSION CHAIN: A SURVEY CONDUCTED IN THE DUTCH HOSPITALS
PARTICULAR BLOOD COMPONENTS IN COMPLICATIONS AFTER TRANSFUSION
THE SAFETY WALK ROUND: A SIMPLE TOOL FOR RISK MANAGEMENT IN TRANSFUSION MEDICINE
HAEMOVIGILANCE- THE MYSTERY OF THE PHANTOM SAMPLE
COMPARATIVE ANALYSIS OF THE INCIDENCE OF COMPLICATIONS AFTER DIFFERENT SPECIFICATION PLATELET CONCENTRATE TRANSFUSIONS
INFLUENCE OF RED BLOOD CELL STORAGE ON POSTOPERATIVE COMPLICATIONS IN ON-PUMP CABG PATIENTS
EVALUATION OF ADVERSE TRANSFUSION REACTIONS FOLLOWING BLOOD PRODUCT TRANSFUSION FROM A TERTIARY CARE HOSPITAL: A PRELIMINARY STEP TOWARDS HEMOVIGILANCE
COMPATIBILE BLOOD FOR PATIENTS WHO DEVELOPED RED BLOOD CELL ALLOANTIBODIES IN BLOOD TRANSFUSION INSTITUTE VOJVODINA 2012
TWO VIGILANCE APPROACHES
IS MALARIA TRANSMISSION THROUGH BLOOD TRANSFUSIONS A PROBLEM FOR MALARIA-ENDEMIC COUNTRIES IN AFRICA?
ROUTINE TRANSFUSION EXPERIENCE IN PEDIATRIC PATIENTS USING PLATELET AND PLASMA COMPONENTS TREATED FOR PATHOGEN INACTIVATION
ROUTINE PRODUCTION AND CLINICAL USE OF MIRASOL®-PLATELETS AND FFP AT THE REGIONAL BTS WARSAW
COMMON CAUSES OF BLOOD TRANSFUSION EVENTS IN A UNIVERSITY HOSPITAL: ANALYSIS OF INCIDENT REPORTS
EVALUATION OF NON INFECTIVE TRANSFUSION REACTIONS REPORTED IN CHC ZEMUN
CROATIAN HAEMOVIGILANCE REPORT 2011
IDENTIFICATION AND REPORTING OF ADVERSE TRANSFUSION REACTIONS IN POLAND
BLOOD SAFETY IN GREECE, 1996-2011: A REPORT FROM THE HELLENIC COORDINATING HAEMOVIGILANCE CENTRE (SKAE)
CLINICAL OUTCOMES OF ABO INCOMPATIBLE RBC TRANSFUSIONS
CLERICAL ERRORS IN BLOOD REQUISITIONS - ANALYSIS OF 17148 REQUISITIONS
FERROPENIC ANAEMIA: IMPROVEMENT OF HEMOGLOBIN WITHOUT BLOOD TRANSFUSION. THE ROLE OF INTRAVENOUS FERRIC CARBOXYMALTOSE - FECARB - (FERINJECT®)
INTRA-OPERATIVE CELL SALVAGE IN REVISION HIP SURGERY
INTRAOPERATIVE TRANSFUSION IN REGIONAL HOSPITAL VALJEVO,SERBIA
THE EFFECT OF APPLYING AUTOLOGOUS BLOOD WITH PATIENTS WHO UNDERGO HIP REPLACEMENT SURGERY
USE OF HUMAN INDUCED PLURIPOTENT STEM CELLS TO MODEL HUMAN FETAL DEFINITIVE HEMATOPOIESIS
GENE EXPRESSION STUDIES OF ERYTHROBLASTS DERIVED FROM DIFFERENT HAEMATOPOIETIC SOURCES
ANALYSIS OF MATERNAL AND NEONATAL FACTORS THAT INFLUENCE THE NUCLEATED AND CD34 + CELL YIELD FOR CORD BLOOD BANKING
EVALUATION OF MNC QUANTITY BY FLOW CYTOMETRY AND HEMATOLOGY COUNTER WITH 5-DIFF IN PORTIONS OF CORD BLOOD COLLECTED IN REGIONAL BLOOD CENTER IN POZNAN IN 2012.
THE EVALUATION OF HHV-8 AMONG CORD BLOOD DONORS BY REAL TIME PCR
QUALITY OF CORD BLOOD UNITS SHIPPED FOR TRANSPLANTATIONS
EX VIVO-EXPANDED BONE MARROW MESENCHYMAL STEM CELLS FACILITATE RECOVERY FROM CHEMICALLY INDUCED ACUTE LIVER DAMAGE
EXPERIENCES WITH AUTOLOGOUS PERIPHERAL BLOOD STEM CELL HARVEST (PBSC)
EFFICACY OF ENGRAFTMENT OF PERIPHERAL BLOOD STEM CELLS COLLECTED WITH THE AMICUS CELL SEPARATOR
A STUDY ON AUTOLOGOUS AND ALLOGENEIC PERIPHERAL BLOOD STEM CELLS TRANSPLANTATION FOR HAEMATOLOGICAL MALIGNANCIES AND BENIGN BLOOD DISORDERS USING APHERESIS TECHONOGLY
STEM CELL IMPLANTATION IN THE TREATMENT OF PERIPHERALVASCULAR DISEASE
STUDY OF FORMING CONDITIONS FOR HEMATOPOIETIC STEM CELLS DONOR REGISTRY BY A PEST ANALYSIS
ALLELE AND HAPLOTYPE FREQUENCIES OF HLA SYSTEM IN RECIPIENTS AND DONORS IN PROTOCOL OF STEM CELL TRANSPLANTATION - CENTRAL BLOOD BANK, MEDICAL CENTER NATIONAL SXXI, IMSS
EVALUATION OF THE PATTERN AND VALUE OF ABO BLOOD GROUP IN PATIENTS RECEIVING ALLOGENIC HLA MATCHED HSC SIBLING TRANSPLANTS WITH DIFFERENT BLOOD GROUPS
P-679
COMPARISON OF MEDIA FOR THE OPTIMAL CULTURE OF TH1 POLARIZING MPLA/INTERFERON GAMMA DC
DEVELOPMENT OF A CLINICAL GRADE CLOSED CELL CULTURE SYSTEM FOR DENDRITIC CELLS USED FOR CANCER IMMUNOTHERAPY
MONONUCLEAR CELLS IN CANCER IMMUNOTHERAPY: THE OPTIMIZATION OF MONONUCLEAR CELLS COLLLECTION TECHNIQUE
P-683
CLINICAL USE OF PERIPHERAL BLOOD CD34+ CELL COUNT AND MIDPOINT COLLECTION CD34+ CELL YIELD FOR PERIPHERAL BLOOD STEM CELL COLLECTIONS FROM AUTOLOGOUS PATIENTS MOBILIZED BY G-CSF AND PLERIXAFOR
PREEMPTIVE USE OF PLERIXAFOR
SAFE COLLECTION OF PERIPHERAL BLOOD STEM CELLS IN PATIENTS AND DONORS USING THE AMICUS® SEPARATOR AND THE SPECTRA OPTIA® APHERESIS SYSTEM
VERY-LARGE VOLUME LEUKAPHERESIS (VLVL) IS SUITABLE FOR COLLECTION OF PERIPHERAL BLOOD PROGENITOR CELLS IN HEALTHY ALLOGENEIC DONORS
PERIPHERAL BLOOD STEM CELL COLLECTION IN HEALTHY DONORS
THE INFLUENCE OF HEMATOCRIT ON HPC SEDIMENTATION
IMPLEMENTATION OF TENDON ALLOGRAFT WITH AUTOLOGOUS BONE MARROW CONCENTRATE TO RECONSTRUCTION ANTERIOR CRUCIATE LIGAMENT
P-691
P-692
QUANTIFICATION OF PLATELET AND GROWTH FACTORS FROM PLATELET-RICH PLASMA IN BETWEEN ELISA VS BEAD BASED MULTIPLEXING TECHNOLOGIES AND ITS IMPLICATION IN NON-HEALING CUTANEOUS WOUNDS
APHERESSIS PLATELETS AND PLATELET CONCENTRATES AS SUPPORT TREATMENT OF ADULT ONCOHEMATOLOGY PATIENTS IN GENERAL HOSPITAL UZICE
BONE MARROW-DERIVED STEM CELL THERAPY FOR AVASCULAR NECROSIS OF THE FEMORAL HEAD
P-696
P-697
ANTIBODY MEDIATED REJECTION AFTER HEART TRANSPLANTATION WITH DE NOVO DONOR SPECIFIC ANTI - HLA ANTIBODIES: CASE REPORT
EVALUATION OF THE NEW METHOD OF LYMPHOCYTE CROSS MATCH ‘LUMINEX BASED DONOR SPECIFIC ANTIBODY SCREENING TEST’ FOR RENAL TRANSPLANT CASES IN SOUTH INDIA
CAN LUMINEX DONOR SPECIFIC ANTIBODY CROSS MATCH BE A BETTER ALTERNATIVE OF COMPLEMENT DEPENDENT CYTOTOXICITY CROSS FOR RENAL TRANSPLANT CASES IN DEVELOPING COUNTRIES LIKE INDIA?